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ABSTRACT 
Fatigue associated with activity is a normal response, seeking to prevent damage 
or conserve energy. Some individuals show heightened fatigue resf.onses with no 
distinct aetiology. In chronic fatigue syndrome (CFS), peripheral fatigue 
mechanisms display no apparent abnormalities, indicating some centra1 
mechanism. Transcranial magnetic stimulation (TMS) was used to compare 
force, perceived exertion, electromyogram response, motor evoked potentials 
(MEP) and silent periods (SP) following stimulation in normal and chronic 
fatigue groups. Participants (n=l2) were physically matched and performed a 
sustained sub-maximal (20% of MVC) isometric contraction of the elbow 
flexors. There were no significant differences (p < 0.05) in elbow flexor strength 
or time to reach fatigue. CFS participants showed a significant difference in 
perception of effort at outset. Differences were also noted in :MEP amplitude 
and SP duration (p<0.05). Controls showed an increase in MEP amplitude and 
SP duration during the fatigue protocol, while CFS group showed no change. 
The central nervous system responses to fatigue in CPS group appears abnormal. 
This confirmed previous studies indicating a change in the normal inhibitory 
response. While specific sites for such disruptions are not indicated, findings 
support literature in suggesting that a disruption to responses of inhibitory 
intemeurones may be responsible. This confirms that a clear and distinct 
pathology is associated with the CFS. Recommendations for further research 
into the process of central fatigue are given. 
_,_. __ , __ , _·._ 
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With high intensity exercise, or a new activity, fatigue will occur. Fatigue is a 
normal response of muscular activity but the causes and sites of fatigue are not 
clearly understood (Ganong, 1987, p. 569; Fox, Bowers, & Foss, 1993, p. 124). 
The fatigue response seeks to limit damage or minimise depletion of energy 
reserves. In the field of exercise science an understanding of the process of 
fatigue can lead to not only improved performance and training methods, but 
also to reduced injury risks associated with excessive muscle activity (Fox et a!. 
1993; Powers & Howley, 1994). 
In some individuals, extreme respon::;es of fatigue occur and result in a state of 
chronic fatigue. This heightened response is debilitating and its cause 
undetermined. Extreme and chronic states of fatigue are also associated with 
general illness, specific disorders such as multiple sclerosis, rheumatoid arthritis, 
or Lyme disease, and some non~specific illnesses such as chronic fatigue 
syndrome (CFS) (Waddy, Wessely, & Murray, 1990; Gordon, 1993, p. 3). In 
CFS, fatigue is persistent and the ability to recuperate impaired. No single 
physiological or biochemical indicator has been identified to explain the onset of 
chronic fatigue in CFS. Further, several researchers suggest a link between 
fhtigue experienced dw ing regular activity, such as sports or exercise, and 
conditions of chronic fatigue states such as CFS (Parry-Billings, Blomstrand, 
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McAndrew, & Newsholme, 1990; Fry, Morton, & Keast, 1991a). As CFS 
frequently follows viral infection, an immunological disruption has been 
suggested as causative. 
The fatigue process due to exercise and training is considered to exist on a 
continuum, where increasing levels of activity lead to an exacerbation of the 
fatigue response, leading to over-fatigue and eventually overtraining (Fry et al. 
1991 a; Rowbottom, Keast, & Morton, 1996). An identifiable state known as 
overtraining syndrome (OTS) is fairly well documented and shares much 
symptomology with CFS (MacKinnon & Hooper, 1992; Parker & Brukner, 
1994). Speculation as to the existence of a fatigue continuum extending to CPS 
has yet to be confirmed (Keast & Morton, 1992; Rowbottom eta!. 1996). A 
diagnostic measure may serve to confirm that fatigue linked to overtraining and 
fatigue linked to CFS are manifestations of the same or a similar process. 
No objective diagnostic tool is currently available for assessing the 
symptomology ofCFS. With exclusion being the guiding criteria, a wide range 
of assumptions and eliminatory tests are currently required (Holmes, 1991). A 
relatively inexpensive tool for determining the status of patients with chronic 
fatigue syndrome could aid both diagnosis and treatment. 
Possible sites for fatigue mechanisms are classified as either peripheral or central. 
Peripheral fatigue refers to those fatigue sites in the muscle, while sites for 
central fatigue arc considered to be located in the motor cortex, spinal cord, or 
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peripheral nerves, refer t(' figure 2.1. No distinct pathology, linked to peripheral 
sites for fatigue, have been detected in CFS which leads to speculation about 
fatigue in the central chain of command sites. 
Voluntary activity of muscles, leading to fatigue, is driven by the motor cortex. 
The possibility of a fatiguing mechanism contained there warrants investigatior .. 
Further, the role that central fatigue plays in the overall fatigue process gives rise 
to the need to investigate such processes in chronic states of fatigue as well as in 
healthy groups. Previouslv. electrical stimulation has been used to elicit post 
fatigue responses in muscles. It is now possible to non-invasively stimulate the 
motor cortex itself This may be done through transcranial magnetic stimulation 
(TMS) at site specific locations (Barker, Jalinous, & Freeston, 1985; Day, 
Dressler, Maertens, Marsden, Nakashima, Rothwell, & Thompson, 1989). 
While widely used in mapping the human motor cortex TMS has also proven 
useful in understanding, exploring and diagnosis of functionality of the human 
body (Mortifee, Stewart, Schulzer, & Eisen, 1994; Stoloy, 1995; Sacco, 
Thickbroom, & Mastaglia, 1996). Muscle responses to TMS, observed by 
electromyogram (EMG}, can provide useful information regarding the motor 
pathway involved. This leads to a need for inquiry into the muscular responses 
to cortical stimulation. 
Neural feedback mechanisms may also be affected through increased inhibitory 
nerve excitation. Such secondary fatigue impediment also needs to be observed. 
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Thus central fatigue must be observed in CFS sufferers and compared to nonnal 
responses to ascertain if any intrinsic abnormalities or differences, which may 
reflect the pathology of the disorder, can be detected 
1. 2 Purpose of the Study 
The purpose of this study is to quantifY central fatigue in chronic fatigue 
syndrome (CFS) following a sustained submaximal isometric contraction of the 
biceps brachii. The time course of fatigue development will be observed and 
compared to a control group. Muscle strength, force-EMG characteristics, 
cortical stimulation responses, time to fatigue, and perceptions of exertion will 
be observed in participants during the fatiguing contractions. 
The aim is to compare the responses to fatiguing voluntary muscle activity 
between individuals with chronic fatigue syndrome (CFS), and normal healthy 
participants. A further aim of the study is for it to act as a pilot study into the 
feasibility of central fatigue measures, or stimulation responses, as an objective 
diagnostic tool. 
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1.3 Hypothesis 
A voluntary, sub~maximal, isometric contraction to .fatigue will display altered 
characteristics for participants with CFS than those in control group. Such 
changes will be manifest by: 
1. Reduced time to onset of fatigue, 
2. Altered perceptions of exertion, and 
3. Altered motor responses to magnetic stimulation of the muscle : such 
as motor evoked potentials (MEP's) and duration ofEMG silent 
period (SP) following stimulation. 
1.4 Organisation of the Thesis 
Chapter One provides an overview of the purpose of the study and a brief 
discussion on the background and significance, as well as outlining the 
hypothesis to be tested. This is followed in Chapter Two by a review of 
literature pertaining to fatigue in activity, central fatigue, chronic fatigue 
syndrome, and transcranial magnetic stimulation (TMS). Chapter Three 
describes the theoretical framework underlying the study, while Chapter Four 
details the methodology and procedures of both study and analysis. Results and 
findings of significance are presented in Chapter Five. A summary of the 
findings, and their link to broader literature and knowledge, is discussed in 
Chapter Six. Chapter Seven, then, presents the conclusions and implications of 
the findings, and suggests direction for future research 
2.1 Introduction 
CHAPTER TWO 
REVIEW OF THE LITERATURE 
Central Fatigue 6 
Muscle fatigue can be described as "a state of physiological inability to contract" 
(Marieb, 1995, p. 270). Such a definition considers the muscle in isolation. This 
a] lows for an understanding of peripheral fatigue processes however it fails to 
account for neurally based fatigue or cortical involvement in voluntary 
movement. Peripheral fatigue mechanisms have been explored for many years 
and physiological mechanisms are relatively well understood (Jones & Round, 
1990), yet the role of neural feedback and central control mechanisms has not 
been fully explored (Malon, 1991). This has largely been due to the invasive 
nature of observing central nervous system (CNS) responses to fatigue. With 
the development oftranscranial magnetic stimulation (TMS) a non-invasive tool 
is now available to enable the CNS and motor pathways to be observed in a safer 
manner (Sacco eta!. 1996). 
Recent studies have searched for a biochemical marker to indicate CFS (Parry-
Billings, Budget!, Koutedakis, Blomstrand, Brooks, Williams, Calder, Pilling, 
Baigrie, & Newsholme, 1992; Keast, Arstein, Harper, Fry, & Morton, 1995; 
Rowbottom eta!. 1996). While some success has been achieved, no single 
marker, useful in diagnosis, has yet been identified (Lloyd & Pender, 1994). The 
extension of the existing continuum of fatigue, from normal activity to 
overtraining syndrome (OTS), to include CFS has yet to be confinmed. 
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Similarities of symptoms between CFS and OTS has lead to speculation about 
extending the continuum offatigue. No research has yet to confirm this (Keast 
& Morton, 1992; Rowbottom et al. 1996). Should such a diagnostically useful 
measure be found this may serve to confirm that CFS is indeed a manifestation 
of a similar process to that accompanying normal activity. Investigation of 
normal fatigue responses may then be extrapolated to having relevance to the 
chronic fatigue sufferer. If, however, a different process is involved much of the 
present thinking on CFS may need serious reviewing. 
In addition to the contractile mechanisms, a second site for fatigue lies within the 
motor cortex and associated peripheral nervous system. An exploration of the 
corticomotor responses of fatigue would prove useful in identitying any central 
fatigue mechanism. A further problem lies in quantifYing fatigue for the purpose 
of diagnosis and treatment. Activation of muscle is driven by the motor cortex, 
thus any possibility of a fatiguing mechanism contained there warrants 
investigation. Skeletal muscle response to TMS can be measured and therefore 
it may be possible to obtain some measurable outcome that reflects central 
fatigue (Edwards & Gibson, 1991 ). 
2.2 Central Fatigue 
In addition to peripheral based definitions, fatigue has also been defined as a 
"failure to sustain muscle force or power output" (Edwards & Gibson, 1991, p. 
4) and as such can be measured. Other definitions refer to the decrease in 
capacity of skeletal muscle to perform work during activity and to increased 
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perceptions of effort associated with such activity (Nethery, 1991). This 'effort 
sense' is more difficult to measure as its origin and processes lie in the cerebral 
cortex. The inclusion of perception in such definitions indicates the close 
association of fatigue and the operations in the cortex. Further, the 
proprioceptive mechanisms returning information to the cortex may have a more 
profound effect on the determination of fatigue as a concept than is currently 
thought. Thus a chain of command for muscle activation is considered to also 
reflect a pathway for fatigue mechanisms. 
The origin of fatigue is thought to reside in one or more links in the chain of 
command (see figure 2.1). The two categories involved are central: involving 
"the central nervous system and nervous pathways'', and peripheral: "events 
occurring within the muscle" (Edwards & Gibson, 1991, p. 4). 
Command Chain 
Motor Cortex 
Spinal Cord 
Peripheral nerves 
Neuromuscular Junction 
Muscle Cell Membrane 
Transverse Tubular System 
Sarcoplasmic Reticulum 
Myofiliments 
Sites for potential fatigue 
Central 
Peripheral 
Figure 2.1. Chain of Command for muscle activation and potential sites for 
fatigue. (Adapted from Lewis & Haller, 1991, p.l26.) 
Central Fatigue 9 
Peripheral fatigue involves the physiological and metabolic measures of fatigue 
present in the muscle. Central fatigue, on the other hand, is indicative of fatigue 
manifested by alterations to the nervous system and the motor cortex processing 
of stimuli for the relevant muscle groups. 
Just as increases in motor drive, or neural processes, affect perfonnance in 
activity and sport, so too reduced stimulation of neural pathways will have a 
performance affect. Reduction of motor drive, or inhibition of motor pathways 
may limit outputs. "Reduced motor drive (central fatigue mechanisms) may 
similarly have profound effects on strength" (Edwards, Clague, Gibson, & 
Helliwell, 1994, p. 251). Thus clinical or subjective evaluations of strength may 
be unreliable. Most such tests are unable to distinguish between peripheral and 
central fatigue and therefore may only be providing a partial picture to the 
diagnostician. A diagnostic procedure that incorporated both peripheral and 
central factors, or which isolated them, should be of benefit in the management 
and treatment of fatigue related illnesses. 
T~ie application of electrophysiological assessment of muscle function has 
proven useful in analysing muscle performance independent of volition (Edwards 
et al. 1994, p. 253). The application of percutaneous electrical stimulation has 
been used for several years with good results. Unfortunately this technique fails 
to account for the motor pathway prior to the neuromuscular junction at the 
motor end plate. 
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Stimulation through TMS, however, may prove beneficial as it "evokes 
compound muscle action potentials (CMAP's) in the healthy subject ... [with] 
shape and amplitude similar to those of electrical stimulation" (Glocker, 
Magistrus, Rosier, & Hess, 1994, p. 118). Given the similar responses between 
electrical and magnetic stimulation and that stimulation of the cortex, through 
TMS, provides information about the central mechanisms linked to fatigue, it is 
clearly beneficial to use TMS. 
Some results would seem to indicate that there is a mismatch between the 
afferent and efferent activity (Edwards eta!. 1994, p. 253). It is suggested that 
an extended silent period following TMS is indicative of the inhibitory processes 
activating . Some research proposes that the Ia inhibitory intemeurones are 
largely responsible (Porter & Lemon, 1993, p. 205; Young, Triggs, & Gerstle, 
1995, p. 1290). The precise role and process of such inhibitory process is 
uncertain. 
In one study Edwards et al. (1994) found indications that CFS patients were 
often not exercising to their physiological capacity, making comparisOns with 
controls extremely difficult. This implies that some voluntary drive process may 
also a limiting factor. By setting any exercise testing parameters in relation to 
the individual's baseline it should be possible to eliminate any ambiguities in the 
results of such testing. By normalising for time, considering time as a portion of 
the total task time, it is considered that observations of identifiable responses 
may be legitimately compared. 
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A further psychological benefit from exercise testing is also suggested by 
Edwarcis '~ "'· (1994, p. 255). Patients may attain some therapeutic benefit from 
having their actual capabilities shown to be greater than they may perceive. 
Further conjecture may be made regarding the patient's ability to self~monitor 
improvements as identified by exercise testing. Such testing, if kept relative to 
the individual, may be the foundation of self-identifiable recovery. While the 
psychological and sociological benefits of such outcomes are far beyond the 
scope of this paper, such benefits are essential for the patient. Existing clinical 
practices do not permit an objective indicator of a measurable capability. Thus, 
there is a need, and a desire, for a simple and effective diagnostic tool for the 
determination of fatigue related illnesses (Lloyd & Pender, 1994). 
It is generally considered that histopathological, metabolic and physiological 
changes in the muscle are not sufficient to explain the symptoms of CFS 
(Edwards et al. 1994, p. 257). It may be that the CFS patient has a lowered 
threshold for sensation during exercise, or that the~r have an "additional 
perception of fatigue at rest over and above that experienced during exercise" 
(Edwards et al. 1994, p. 256). Past inat;!iry to determine any such effect on 
effort sense may have more to do with study design. The linking of a measure of 
perceived exertion with physiological correlates may shed some light on this 
grey area. 
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Failure to determine any differences in motor pathways from central triggering, 
may indicate disturbances in the higher, 'executive' pathways. Such speculation 
is again beyond the scope of the present study. 
Central fatigue relates to a reduced motor drive leading to a faiiUJ:e to maintain 
muscle activation, while peripheral fatigue, in contrast, involves processes of the 
contractile mechanisms within the muscle itself Lewis and Haller (1991) point 
to the "paucity of data ... comparing voluntary and involuntary contraction" (p. 
124). The majority of studies to date seem concerned with peripheral fatigue as 
responsible for voluntary fatigue in healthy participants yet little research seems 
to have been conducted on patients suffering CFS. In the case ofCFS most 
physiological and biochemical responses of muscle appear normal. Some 
innovative work is currently raising hopes regarding glutamine levels as a readily 
identifiable blood born indicator but as yet this is still in the research phase 
(Rowbottom et at. 1996). 
Central fatigue, therefore, is a failure to achieve full voluntary activation of 
motor units and either conscious or unconscious mechanisms may be 
responsible. Conscious mechanisms prevail when an individual decides that 
sensations from proprioceptive feedback mechanisms are unacceptable. The 
individual then consciously reduces activity (Jones & Round, 1990, p. 135). 
Such reductions may be linked to either a real or perceived sense of effort. 
Unconscious mechanisms are reflected through afferent infonnation from 
muscle, joint or tendons, which modulate activity at a spinal or supra-spinal 
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level. In much the same way that inhibitory intemeurones limit force production 
in unusual activity, excessive feedback may manifest in an altered perception of 
fatigue or have some unknown effect on the processing of fatigue responses in 
the cortex. An exploration of the neural responses during fatiguing activity may 
yield information about the interaction between central and peripheral fatigue 
mechanisms. 
2.3 Chronic Fatigue Syndrome (CFSl 
A major problem in understanding chronic fatigue in a variety of illnesses is the 
elusive nature of a definition. For illnesses of undetermined aetiology the 
problem is exacerbated. Thus, clear case definitions are required, and indeed are 
being developed and reviewed. These generally seek to facilitate both research 
and treatment (Lloyd & Pender, 1994). 
The development of a standard case definition is an important step 
toward understanding and studying any illness of unknown aetiology. 
A standard case definition facilitates research because it enhances the 
comparability of the experiences or study results that are obtained by 
clinicians and investigators in the field (Holmes, 1991, p. 853). 
During the later halfofthis century, especially in the 1980's, an apparently new 
chronic illness, characterised by multiple non-specific chronic symptoms, 
absence of abnormal physical findings, and associated with "apparently elevated 
titres of Epstein-Barr virus" (Holmes, 1991, p. S54). The syndrome became 
known as Chronic Epstein Barr virus disease (CEBV). Early reports of elevated 
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titres later conflicted with apparent relationship with controls. In addition 
several other viral triggers where noted or suspected, such as the Coxsackie 
virus. These eerly anomalies where generated through inconsistent and 
occasionally conflicting definitions (Holmes 1991, p. 854; Beam & Wessely, 
1994, p. 79). 
Without knowing what is being referred to it is possible for clinicians and 
researchers to use differing titles and definitions to refer to essentially the same 
illness. More recent research findings indicate a limited association '.vith any 
specific virus such as Coxsackie or Epstein-Barr. Linking specific viral issues to 
the naming of the disorder was less specific and proved unreliable. International 
consensus is to use the term 'chronic fatigue syndrome' as it is brief, accurate 
and avoids assumption of aetiology (Beam & Wessely, 1994, p. 79). 
CPS is characterised by persisting, or relapsing, unexplained fatigue and 
exhaustion after even mild exertion. Symptoms include myalgia, sore throat, 
difficulty sleeping and lethargy, similar to post-viral responses. Psychological 
disturbance in mood, memory and concentration are also noted, though most 
psychological symptoms are regarded as reactive (Parker & Brukner, 1994). 
While initially diagnosed in 1869 (Parker & Brukner, 1994) several terms have 
been used to describe CFS, including Chronic Epstein Barr Virus, Royal Free 
Disease, and post-Viral Syndrome. CFS is a debilitating illness that has had 
much attention since the early 1980's. Various aetiologies have been postulated 
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with some contention as to the mechanism ofCFS. Generally it is perceived to 
be an immunological cause yet this is not reflected in its varied symptomology 
(Parker & Brukner, 1994). 
General feelings of lethargy and fatigue often follow acute viral infection 
associated with onset of both CFS and OTS. However, some cases have no 
discernible immunologic link. Generally, diagnosis is through exclusion of any 
other pathological responses, or traceable viral responses (Parker & Brukner, 
1994; Fukuda, Straus, Rickie, Sharpe, Dobbins, & Komaroff, 1994). One major 
diffic"lty for diagnosing CFS is the elimination of other medical problems, or 
psychiatric disturbances. 
A range of conditions and illnesses have been described as CFS. Fry, Morton, & 
Keast ( 1991 b) produced a list of such that have been referred to as CFS in the 
past, to indicate the broad range of illnesses and diseases that share common 
traits and the vast range of potential causes that are linked to CFS. (This list is 
reproduced in table 2.1 ). 
A primary problem in researching CPS is the need for a clear case definition 
(Beam & Wessely, 1994). To remedy this situation the Centers for Disease 
Control (Atlanta, USA) convened a meeting in 1987 to develop a working case 
definition (Holmes, Kaplan, Gantz, Komaroff, Schonberger, Straus, Jones, 
Dubois, Cunningharn-Rundles, Pahwa, Tosato, Zegans, Purtilo, Brown, 
Schooley, & Brus, 1988; Holmes, 1991, S54). A summary of the arising 
definition is located in table 2.2. 
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Table 2. I 
Conditions which have been described as chronic fatigue syndrome 
Addington disease 
Akureyi disease 
Allergic fatigue syndrome 
Allergic tension fatigue syndrome 
Anxiety neurosis 
Anxiety reaction 
Autonomic imbalance 
Benign myalgic encephalomyelitis 
Cardiac neurosis 
Chronic Epstein-Barr virus infection 
Chronic hyperfatiguability syndrome 
Chronic mononeucleosis 
Chronic mononucleosis-like syndrome 
Combat fatigue 
Da Costa's syndrome 
Disordered action of the heart 
Effort syndrome 
Epidemic myalgic encephalomyelitis 
Epidemic vegetative neuritis 
Icelandic disease 
Irritable heart 
Lake Tahoe mystery disease 
Myalgic encephalomyelitis 
Nervous exhaustion 
Nervous tachycardia 
(From Fry, Morton, & Keast, 199Ib) 
Neuritis vegetiva 
Neurasthenia 
Neuromyasthenia 
Neurocirculatory asthenia 
Post viral fatigue syndrome 
Post infection fatigue syndrome 
Psychoneurosis 
Royal Free disease 
Shell shock 
Soldiers heart 
Somatization reaction general 
Somatization psychogenic asthenic 
reaction 
Somatization psychogenic 
cardiovascular reaction 
Somatization reaction psychogenic 
cardiovascular reaction 
Syndrome X 
Tapanui flu 
Vasa regulatory asthenia 
Vasomotor instability 
Vasomotor neurosis 
Yuppie flu 
20th Century disease 
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Table 2.2 
SummaJY ofthe working case definition of Chronic Fatigue Syndrome (CFS) 
Both major criteria and either :::: 6 symptomatic criteria plus ;;:: 2 physical criteria 
or ;;:: 8 symptomatic criteria must be present to fulfil the case definition. 
Major criteria 
Persistent or relapsing fatigue or easy fatiguability that: 
' does not resolve with bed rest 
is severe enough to reduce average daily activity by ~ 50% 
Other chronic clinical conditions have been satisfactorily excluded, including 
pre-r· · ;;ting psychiatric disease. 
Minor criteria 
Symptomatic or historical criteria : persistent or recurring symptoms lasting ::::: 6 
months: 
Mild fever (37.5° C-33.6° Coral if documented by the patient) or chills 
Sore throat 
Lymph node pain in anterior or posterior cervical or axillary chains 
Unexplaineti generalised muscle weakness 
Muscle discomfort, myalgia 
Prolonged (?.24 h) generalised fatigue following previously tolerable levels of 
exercise 
New, generalised headaches 
Migratory noninflammatory arthralgia 
Neuropsychological symptoms 
photophobia 
transient visual scotomata 
forgetfulness 
excessive irritability 
Sleep disturbance 
confusion 
difficulty thinking 
inability to concentrate 
depression 
Patient's description of initial onset of symptoms as acute or subacute 
Physical critel'ia: do<.;umented by a physician on at least two occasions, at least 
I month apart: 
I. Low grade fever (37.6° C-38.6° Coral or 37.8° C-38.8° C rectal) 
2. Nonexudative pharyngitis 
3. Palpable or tender anterior or posterior cervical or axillary lymph nodes (<2 
em in diameter). 
Holmes, 1991, p. S54 (adapted from Holmes et al,. 1988) 
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The case definition ofCFS developed, permits an inclusive approach for several 
fields of inquiry. Fields such as anthropology, epidemiology, immunology, 
history, medicine, neurology, physiology, psychiatry, psychology, sociology, and 
virology all have a legitimate interest in CFS research (Beam & Wessely, 1994). 
A clear case definition is useful in permitting communication between and across 
fields of inquiry. 
The removal of previous modifiers such as 'post viral' or 'immune deficiency' 
permits speculation on a variety of aetiological agents. This allows an integrated 
approach to a complex illness that may have physical, social and psychological 
effects on the patient. While still largely exclusion based, the integration of 
several major and minor criteria allow diagnosis to be made relatively accurately. 
In addition it will, until a more accurate aetiology is found, permit the relating of 
both physiological and psychological research to assist in the diagnosis and 
management of this debilitating illness. 
While not all symptoms occur for each individual, a combination of symptoms, 
especially if post-viral, may indicate CFS. It is interesting to note that many of 
the symptoms for CFS are identical to those for overtraining syndrome (OTS) 
outlined in table 2.3 (MacKinnon & Hooper, 1991 ). OTS presents as a state of 
chronic fatigue in athletes who have been seen to train beyond their essential 
recovery limits. 
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Table 2.3 
Sample of various symptoms common to CFS and OTS 
Physical 
Decrements in perfonnance 
Inability to maintain training load 
Chronic fatigue 
Elevated resting heart rate 
Hormonal changes 
Low serum ferritin levels 
Persistent muscle soreness 
Frequent illness (colds, flu, etc) 
(Adapted from Fry, Morton & Keast, 199lb) 
Emotional/Behavioural 
Depression 
Decreased self-confidence 
Mood changes 
Apathy 
Lethargy 
Low motivation 
Lack of concentration 
Anxiety 
This common symptomology provides a clear link with the process of normal 
fatigue, due to physical activity, which presents with similar symptoms to those 
ofCFS. Some biochemical links have recently been indicated between ti~~-,e two 
syndromes (Rowbottom et a!. 1996). The prevalence of so much in common 
lends credence to extending the fatigue continuum (Keast & Morton, 1992) to 
include CFS. This connection between the two syndromes needs clarification 
before a clear and objective diagnostic tool can be developed. 
The CFS represents a significant cause of morbidity and economic burden in 
Australia. The estimated cost to Australia's healthcare system is in the vicinity of 
$59 million (Lloyd & Pender, 1992). This includes costs directly related to 
treatment and indirectly associated treatment for subsequent relapses and 
psychological problems associated with CFS. However, it does not account for 
costs associated with lost productivity, nor for the distress and problems of 
stress placed on family and friends of the primary sufferer. A further cost 
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associated with CFS is the practice of'diagnosis shopping'. This is a fairly 
common practice with CFS, where sufferers attend several medical practitioners 
until they attain a satisfactory explanation or diagnosis. A clearer picture of the 
process of fatigue will assist in improved diagnosis and reduced expense, both to 
the community and the individual. 
Despite numerous studies, little evidence of neuromuscular pathology or 
peripheral neurophysiological abnormalities have been found which could 
account for the chronic fatigue and post-exercise exhaustion which are features 
of this condition. In conclusion then, fatiguability in CFS cannot be accounted 
for by muscle contractile failure or other physiologically determinable 
mechanisms. Nor is a lack of motivation proven to be responsible. Hence, 
peripheral fatigue sites are not considered as causative. Therefore, the 
possibility of some central, corticomotor pathway mechanism involvement in the 
syndrome warrants further study. 
2.4 Fatigue in Exercise and Overtraining Syndrome (OTS) 
Fatigue related to high intensity activity and excessive exercising has been 
explored for many years. Clear physical signs are frequently monitored in 
athletes to minimise the effect of fatigue on training and performance. However, 
some athletes still manage to exceed their limits and are known to fall into a 
state of fatigue that persists and can become a chronic state of fatigue. This has 
come to be known as overtraining syndrome (OTS). OTS has been defined as 
"Prolonged fatigue and under-performance following periods of heavy training" 
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(Rowbottom et al. 1996, p. 3). Fatigue is considered to lie on a continuum with 
OTS and normal responses at opposing ends. 
While first identified in the early part ofthls century, a variety of terms have 
been used to describe essentia1ly the same condition (MacKinnon & Hooper, 
1991). These include 'overstress', 'staleness', 'burnout', 'failing adaptation', 
and 'overreaching'. The use of differing terminology invariably leads to 
confusion, not only for the suffering athlete but also the diagnostician. 
Regardless of the sport, overtrained athletes exhibit similar symptoms, including 
poor or inconsistent perfonnance, inability to train or compete and the 
experiencing of prolonged bouts offatigue (Fry et al. 199la; MacKinnon & 
Hooper, 1991). 
The defining of OTS, like CFS, is difficult as no physiological or biochemical 
measure is available. However in the case of overtrained athletes, in-situ 
evaluation ofperfonnances gives a field assessment of measurable decrements in 
performance. This is often associated with reports of extended lethargy and 
tiredness (Fry et al. 199la; Fry et al. 1991b; Parker, Brukner & Rosier, 1996). 
This performance monitoring may act as an objective tool for early diagnosis. In 
the case of OTS, early identification can prevent a worsening condition and 
more serious problems. 
The symptoms of overtraining have been wide and varied with few cases 
exhibiting precisely the same symptoms in precisely the same order. In a 
j 
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comprehensive review ofOTS symptoms, Fry, Morton, and Keast (199lc) 
reported 317 varying symptoms in 12 categories, refer to table 2.4. 
Further, more consistent symptoms include; elevated basal and resting heart 
rates; elevated blood pressures; low motivation; lethargy; depression; or 
increased susceptibility to illness (Fry et al. 199lc, p 48). While not all 
symptoms appear in OTS, a combination of several is invariably seen in 
overtraining. A more comprehensive listing is available in Appendix D. 
Table 2.4. 
Factors attributed to excessive exercise stress : The symptoms of overtraining 
Category Number of 
Biochemicai/Haematological 15 
Cardiorespiratory function 24 
Drinking/Nutritional Disorders 12 
Hormonal 23 
Inti::ctious disease 49 
Musckuloskeletal complaints 17 
Performance related 17 
Physical 13 
Physiological 13 
Psychological 91 
Sensorimotor performance 25 
Sleep related 7 
From Fry, Morton, & Keast (199Ic, p. 48-52). Full listing available in appendix 
D. Full references available from authors. 
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These prolonged bouts of fatigue are similar in their debilitating nature to those 
ofCFS. This has led to speculation as to extending the fatigue continuum to 
include CFS (Rowbottom et al. 1996). While little has been found to support 
such continuum theory, the similarity ofsymptomology is too great to ignore 
further exploration. As can be seen in table 2.3, previously, the common 
symptoms of both OTS and CFS are diverse. However, it has yet to be shown 
whether the same aetiological process is responsible for such similar 
symptomatology. Should the same process be responsible then observation of 
fatigue processes in healthy people may be of benefit in understanding states 
such as OTS and CFS. 
2.5 Muscle Fatigue and Motor Cortex Responses 
Altered physiology can lead to reorganisation of the motor cortex (Wilson, 
Lockwood, & Thickbroom, 1993 ). This predominantly occurs with spinal 
lesions and amputations. Unfortunately little research exists on fatigue 
responses of the motor cortex during activity. Further questions remain as to 
whether physiology is altered due to immunological dysfunction and how this 
relates to muscular and perceived exertion. Most of the measured alterations are 
in relation to spinal lesions and amputations (Wilson eta!. 1993). 
Historically this has been due to a reliance on invasive methods of measuring 
response. Until recently most measures of cortical response involved sub-cranial 
placement of electrodes. While this has served as a great tool for understanding 
the functioning of the motor cortex, it has precluded studies of active healthy 
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participants. With the development oftranscranial magnetic stimulation (TMS) 
a non-invasive means of observing responses to motor cortex stimulation is 
available. 
The study of corticomotor responses during exercise will address the possibility 
of a central mechanism for those symptoms aSsociated with CFS. It is 
anticipated that this study will provide insight into the fatigue mechanisms of 
chronic fatigue states, and CFS in particular, and may add weight to the 
argument of the existence of a continuum of fatigue (Rowbottom et a!. 1996). 
2.6 Transcranial Magnetic Stimulation of the Cerebral Cortex. 
The cerebral cortex is involved in mental activities such as conscious thinking, 
reasoning, learning, memory, intelligence, and sense of responsibility. It is also 
concerned with perception of the senses and the initiation and control of 
voluntary muscle contraction (Newton & Joyce, 1990, p. 259). 
Motor areas are regions where electrical stimulation produces and controls 
muscular movement (Newton & Joyce, 1990, p. 260). Until recently, 
stimulation of the motor cortex has been possible by maintaining direct contact, 
either intraoperatively or subdurally (Wilson et a!. 1993). Although these studies 
have provided fundamental insights into the organisation of the motor cortex, 
their usefulness has been limited by their invasive nature and by ethical 
consideration since studies have largely been confined to patients undergoing 
surgery (Wilson et a!. 1993). 
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With TMS the cortex is painlessly stimulated as a consequence of the rapid 
discharge of current through a magnetic coil held over the scalp (Barker et al. 
1985). The technique uses a large pulse of magnetic field to induce currents 
below the stimulus point. The current flow induced in the underlying cortex by 
the magnetic pulse is sufficient to activate neurones trans-synapticaUy (Day et al. 
1989) and, under some circumstances, directly (Berdelli, Inghilleri, Cruccu, & 
Manfredi, 1990; Wilson et al. 1993). When the membrane excitability reaches 
threshold, a measurable response of the motor evoked potential (MEP) is 
recorded by surface electromyogram (EMG). The size of the MEP is directly 
related to the number ofmotorneurones activated, hence the excitability of the 
motor pathway is dependant on the stimulus intensity (Valles-Sole, Tolosa, & 
Pujol, 1992). Thus, TMS provides a tool which can compare a known stimulus 
with a measurable response. An example of the MEP induced by TMS is 
presented in figure 2.2. The MEP response measurable, the peak to peak 
summation, and the silent period (SP) measures are indicated. 
TMS has been used in exploratory studies of the corticomotor representation, 
particularly under conditions of altered physiology (Wilson et al. 1993). It has 
further been used to examine duration of silent periods following stimulation and 
to explore central fatigue processes (Fritz, Braune, Pylatiuk, & Wagner, 1995; 
Miller, Braun, & Weiner, 1995; Mortiani, 1995). Given the link between CFS 
and OTS, and physiological fatigue adaptations it would seem reasonable to 
expect some alteration in cortical drive. 
"·'I"' 
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Figure 2.2. Example of an evoked potential (MEP) due to TMS, 
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S5.7721 
' 
AA = SP duration ; BB = MEP (peak to peak summation). 
2.7 Summary 
The close associations between extreme fatigue due, to exercise, such as OTS, 
and CFS in both onset and symptomology support the suggestion of a fatigue 
continuum. While no biochemical or physiological marker of either syndrome 
currently exists both are difficult to diagnose and treat. This leads to a need to 
determine the location of the fatigue mechanisms underlying the syndromes. The 
processing of motor control via the cerebral cortex seems to suggest that a 
central fatigue mechanisro might be located in the motor cortex. Such evidence 
is lacking in the current literature and therefore warrants further examination. 
The recent advances in non-invasive magnetic cortical stimulation pennit an 
observation of motor pathway responses and thereby may provide some measure 
of central fatigue in these debilitating conditions. 
CHAPTER THREE 
THEORETICAL FRAMEWORK 
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The origin for activation of muscles lies in the motor cortex and through motor 
pathways. As muscular activity is so closely linked with neuromuscular 
interaction so too some myalgic illnesses may be more closely linked to the 
motor pathways than is currently suspected. States of chronic fatigue are related 
to excessive activity, such as overtraining syndrome (OTS). This activity linked 
syndrome shares many symptoms with chronic fatigue syndrome (CFS). Given 
the lack of identifiable peripheral aetiology for CFS an exploration of the motor 
pathways is required. 
Non-invasive magnetic stimulation of the motor cortex provides a tool for such 
research. Stimulation of motor drive sites pennits observation of responses to 
stimulation. These responses may be assessed and regarded as reflective of the 
motor pathway processes. In so doing it may prove possible to identity altered 
fatigue responses of the central nervous system that to date have been 
unreported. Such a diagnostic tool may have benefits for CPS sufferers as well 
as- for other states of severe fatigue or other neurological dysfunctions. 
It is suggested that responses to fatigue, of the motor pathway, may encompass 
altered responses such as duration and amplitude of motor evoked potentials. 
Observation of any such changes will serve to improve the understanding of 
fatigue processes. They may also serve to indicate relative intensity of chronic 
fatigue states, thus providing an objective diagnostic tool. 
4. I Design of Study 
CHAPTER FOUR 
METHODOLOGY 
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A between groups comparison design was used to observe any differences in 
responses to exercise. The two groups were closely matched for age, gender 
and activity levels and a single observation was taken. Activity levels were 
indicated using a self report scale (Sharkey, 1991, p. 61), see appendix H. Thus, 
leaving the previously confirmed condition ofCFS as the prime determinant 
responsible for any variation. 
4.2 Outline 
Maximal voluntary contraction (MVC) forces were measured prior to, during, 
and after a fatiguing exercise protocoL These, along with electromyogram 
(EMG) readings of evoked potentials and manually recorded ratings of 
perceived ex:ertion (RPE) were compared to evaluate any differences in the 
process of fatigue, the integration of, or reaction to the fatigue process induced 
by exercise. Force and EMG measures of the twitch interpolation, peak to peak 
amplitude, and subsequent silent period (SP) induced by TMS were also 
followed. Comparisons of the two groups were made to assess and explain any 
differences found. For the purposes of this study, only those participants with 
onset post viral infection, who met diagnostic criteria (table 2.2), and had been 
diat,mosed within the past three years were considered. Furthermore, 
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participants did not have any related medical conditions, psychological, or 
psychiatric influences. 
4.3 Participants 
The participants (n=l2), mean age 29 years (range 18.2 years to 47.8 years), 
were not currently participating in upper body training, such as weight training. 
Participants formed a convenience sample and were selected from two 
categories; clinically determined CFS and healthy controls. Participants were 
informed as to the procedures prior to participation and written consent was 
obtained, refer to appendix A. Participants were briefed on the procedure at 
initial contact and again immediately prior to testing. They were infonned that 
they may withdraw from the study at any stage without consequence. All 
procedures had prior approval from the Edith Cowan University Ethics 
Committee and the Sir Charles Gairdner Hospital Ethics Committee. 
4.3 .1 CFS Group 
Participants in the CFS group (n=6), mean age 31.3 years (range 18.3 years to 
47.8 years), consisted of four females and two males who had been previously 
diagnosed with chronic fatigue syndrome, contracted post virally, and met 
diagnostic criteria as detailed earlier. Histories were reviewed to ensure that 
other neuromuscular, medical and psychiatric conditions were excluded. A 
summary of the history and status of these participants is detailed in appendix G. 
Participants were volunteers drawn from a local CFS support group, covering 
the metropolitan area of Perth, and from centrally located medical practitioners. 
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4.3.2 Control Group 
Control group participants (n~6), mean age 26.6 years (range 19.3 years to 39.4 
years), consisted of four females and two males, and were selected to match, as 
closely as possible, the CFS group. Groups were matched for age, gender, and 
current activity levels as indicated on a self report scale, see appendix H. 
Participants were all currently non-participatory in upper body strength training. 
Healthy controls were drawn from volunteers drawn from the staff and student 
bodies of the Edith Cowan University 
4.4 Instrumentation 
Instruments used for this study included: 
Analog to Digital Converter 
Data test sheets (Appendix I) 
Goniometer 
IBM Microprocessor 
Kin-Com Isokinetic Dynamometer (Chattex Corp., USA) 
Magstim 200 Magnetic Stimulator (Magstim Co., UK) 
Preacher Bench ( 45') modified 
Sapphire EMG machine 
SUN Microprocessor 
Surface EMG electrodes (I em diameter, Grass) 
Translucent rubber cap, adhesives tape, electrode gel 
·,,; 
Central Fatigue 31 
4.5 Instrument Protocol 
4.5.1 Magnetic Stimulation 
Transcranial magnetic stimulation (TMS) of the motor cortex was carried out 
using aMagstim 200 magnetic stimulator (Magstim Co., U.K.) (appendix B). 
A 50 rom diameter figure eight coil was used to magnetically stimulate the site 
found best to affect the non-dominant arm. The figure eight coil configuration 
provides stimulation to a specific area, essential for this study. A flexible skull 
cap, with markings radiating from the apex and spaced I em apart, permitted 
repeated locations at the same site. The stimulator was held tangential to the 
skull, handle posterior, with the centre of the coil over the site to be stimulated. 
This anterior posterior positioning has been found to produce the most 
consistent responses (Fritz, Braune, Pylatiuk, & Wagner, 1995). The threshold 
for responses in the biceps brachii muscle was determined and a stimulus of20% 
above threshold was used for all participants. A computer (386-PC) digitised 
and displayed the data, with analysis conducted later through a SUN 
microsystems workstation using custom designed software. 
4.5.2 EMG Activity 
Surface electrodes were used to record motor evoked potentials (MEP's) and 
EMG activity of the muscle. Two gold electrodes (Grass), I em in diameter, 
were placed, 3 em part, over the distal portion ofthe biceps brachii. Signals 
were processed through a Sapphire EMG analyser and the amplified signal was 
both high and low pass filtered prior to being digitised in an independent PC 
(386). Measures of elbow flexion force and EMG activity were combined in a 
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purpose built software package and transferred to a SUN station for later 
analysis. Manual recordings of test duration and perceived exertion were later 
matched to computerised data. 
4.5.3 Force Mea3ures 
A kinetic communicator (KinCom) isokinetic dynamometer measured force 
output at the wrist. A purpose built preacher curl bench supported the ann at 
45° from horizontal, with an elbow flexion of90°. A gravity allowance was 
made while the participants arm was in a state of relaxation. Force measures 
were displayed in a moving line format on a colour monitor to enable the 
participant to maintain a steady submaximal output of20% MVC. 
4.5.4 Perceived Exertion 
Perceived exertion was monitored using a modified Borg scale (Borg, 1982), 
with participants reporting on their perceived exertion in relation to a maximal 
contraction. The Borg scale was presented on a large chart, a reduced version is 
presented in appendix J. Participants were asked to report, using the Borg scale, 
on how they sensed effort in relation to the previously measured MVC. Other 
comments on physical sensation were reported on at the same time but cast no 
bearing on the present study. 
4.5.5 Activity Index 
Participants completed an activity index questionnaire prior to commencement. 
This permitted cross matching of the control group and was based on a 
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previously used model (Sharkey, 1991). This provided a measure of the 
participant's self determined activity level on a scale of one to I 00. A copy of 
the activity index used is available in appendix H. 
4.5.6 Miscellaneous 
MEP's were digitised and recorded for analysis on a microprocessor (386-PC). 
In addition to the peak to peak amplitude of stimulated :MEP response, the time 
course of the post MEP silent period (SP) was also followed. This permitted the 
state of excitation to be observed and correlated with the stimulus response. 
Results of data were analysed in digitised fonn on a SUN station. Time course 
of SP duration was measured individually for each stimulation .. 
All measures were taken in a single visit to the Australian Neuromuscular 
Research Institute (ANRI). Sessions lasted approximately two hours. 
4.6 Test Procedures 
Participants were seated astride a purpose built preacher curl bench with the arm 
supported at 45° from horizontal, with an elbow flexion of90°. Force, of the 
elbow flexors, was measured at the wrist continuously by a computerised 
isokinetic dynamometer (Kin-Com), with readouts displayed graphically to 
participants via a colour PC monitor. 
The operation and purpose of the Borg scale for perceived exertion was 
explained to participants and the entire test protocol was explained a second 
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time. Participants were permitted to familiarise themselves with the Borg scale 
and with the movement of the target line on the computer monitor. 
4.6 .I Protocol 
To establish individual maximal force, each participant performed three MVC's 
of three seconds duration with 60 seconds rest between each contraction. 
Average of the best two performances was the basis for determining the 
submaximal activity level used, set at 20% MVC. Baseline MEP and SP 
measures were taken. Participants then proceeded to perform the sustained 
isometric contraction until fatigue. 
The sub maximal fatigue test consisted of sustaining a target line, displayed on 
the PC monitor, at 20% ofMVC until fatigue. Fatigue was determined by an 
inability to maintain target force for three seconds. At this point participants 
were encouraged to make a continuous maximal effort lasting ten seconds. 
Force and EMG were monitored continuously by computer. Rates of perceived 
exertion (RPE) were asses~cd each minute until exhaustion using a modified 
Borg scale (Borg, 1982). Magnetic stimulation ocr.;uJTed each minute and 
responses recorded via an independent computer. 
4.7 Data Analysis and Statistical Analysis 
Data was analysed using purpose designed software (Waves) on a Sun Station 
micro processor. Subsequent data was further analysed using Microsoft Excel 
version 5.0. Differences in participant responses to all measures during activity 
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were compared using non-paired Mann-Whitney U-tests, or paired Wilcoxon 
signed ranks tests. The significance of changes in parameters measured over the 
course of fatiguing exercise was determined using the Friedman two-way 
analysis of variance by ranks. All statistical analyses were conducted using the 
statistical package for social sciences (SPSS for Windows, version 6.0}, with 
significance taken at the 95% confidence interval (p :s; 0.05). 
4.8 Limitations and Assumptions 
4.8.1 Participant Limitations 
The participants may differ in strength, level of daily activity, and susceptibility 
to fatigue. These individual differences may contribute to a variability in 
responses. In order to minimise this risk, cross matching of participants was 
conducted and all participants were required to be non-participatory in upper 
body strength training. A further limitation included the participant's ability to 
maintain voluntary contraction for the duration of the exercise. The subjective 
nature of the RPE scale interpretation risked leading to some ambiguity. This 
was checked for consistency within groups. It was assumed that participants 
would participate with maximal effort until volitional fatigue. 
4.8.2 Delimitations 
Delimitations include the availability of suitable participants as determined by the 
exclusion criteria and selection processes. The time available for the use of 
neurology clinic equipment (ANRI) restricted the study and this limited the 
number of possible testing sessions. 
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4.8.3 Musc-le Recording Limitations 
While the use of surface electrodes is non-invasive it is difficult to obtain precise 
recordings from single muscles. Activity from surrounding muscles might also 
be recorded. Accurate location, based on anatomical landmarks, assisted in 
minimising such peripheral input to MEP recordings. 
4.8.4 Data Limitations 
Limitations on data analysis included the limited scope of studies involving 
normal and CFS participants. This study sought to augment the limited 
information regarding stimulated responses in a normal population. Further, 
results of control groups were checked with previously existing data, obtained 
by the ANRI on healthy participants, to confirm validity of observations. 
CHAPTER FIVE 
RESULTS 
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Individual results and data, normalised for time, are located in appendix E. All 
group means are expressed in text± standard error of the mean (SEM). The range 
oftimes taken to complete fatigue protocol made comparison of data between 
individuals difficult. This was overcome by normalising for the time on task (TOT) 
and extracting values at start, 20%, 40%, 60%, 80%, and 100% of TOT. The total 
time was considered and the nearest stimulation, producing an MEP, was taken as 
the normalised data point for each participant. This permitted a compariron 
between groups using the same baseline, time related, scale. 
One participant, CFS 2, recorded post recovery MVC force in excess of initial 
MVC, This was regarded as indicative of a failure to achieve true maximal force 
initially and as such submaximalloads would have been too low. For the purposes 
of strength comparisons data for CFS 2 has been discarded. 
5. 1 Participants 
Participants age, weight, height, and activity index (AI) data was evaluated and 
tested using Mann Whitney U test and a test of means for age and activity index 
(AI). Physiological parameters appear in table 5.1 (CON) and table 5.2 (CFS) 
below. No significant differences were found between groups, for age or AI, at a 
probability value of p ~ 0.05 . Initial MVC force also showed no significant 
difference between groups at p $. 0.05 . 
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Table 5.1 
Phxsiological garameters for control groun (COl'!) 
Subject Sex Age Mass (kg) Height (em) AI Initial MVC 
CON1 m 19.3 70.0 168 64 226.8 
CON2 f 37.8 60.0 173 12 139.0 
CON3 f 39.4 54.0 157 64 184.0 
CON4 m 21.3 82.0 190 36 200.0 
CONS f 22.5 62.0 166 64 100.7 
CON6 f 19.6 55.0 163 48 131.0 
range 19.3-39.4 54-82 157-190 12-64 100.7-226.8 
mean 26.6 63.8 169.5 48.0 163.6 
SIOM ± 3.8 4.3 4.6 8.6 19.5 
SEM =standard error of means 
Table 5.2 
P!Jl!siological garameters for chronic fatigue groug (CFS) 
Subject Sex Age Mass (kg) Height (em) AI Initial MVC 
CFS1 f 28.8 64 175 6 118.0 
CFS2 m 47.8 92 183 64 80.0 
CFS3 f 46.9 76 180 6 96.8 
CFS4 m 27.0 63 155 27 221.0 
CFS5 f 18.9 52 163 64 107.0 
CFS6 f 18.3 57 165 6 118.0 
range 18.3-47.8 52-92 155-183 6.-64 80- 221 
mean 31.3 67.3 170.2 28.8 123.5 
SEM ± 5.4 5.9 4.4 11.6 20.4 
SEM- standard error of means 
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5.2 Time on Task 
Mann Whitney U test of the time on task (TOT) for each group also showed no 
significant differences (p ~ 0.05), with controls exhibiting a mean TOT of 17.7 (± 
3.5) winutes, and CFS having mean TOT of 14.5 (± 4.5) minutes. 
While the time on task was not statistically significant it is important to note the 
ranges covered (CON- 10 to 29 minutes; CFS - 6 to 32 minutes). Figure 5.1, 
below, shows clearly that while no participants in the control groups were less than 
10 minutes TOT, the CFS group had three (50% of group) subjects less than 10 
minutes TOT. 
Spread ofTime on Task (TOT) 
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Figure 5 .1. Time on task for both groups, three CFS subjects< ten minutes. 
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5.3 Force Production 
Isometric force was monitored throughout and following a recovery period. Force 
measurements were normalised and expressed as a percentage of initial MVC 
force. This was done to reduce variability for comparison between individuals. 
Maximum force production at the end offatigue in the CFS groups fell to 54.5% 
(± 6.2 %) of initial MVC force, while control group dropped to 53.0 %, (± 4.4 %) 
of initial MVC. Mann \\rhitney U Tests showed no significant differences, between 
groups (p s 0.05), between starting forces and forces at the end of fatigue 
protocol. However, by the end of a 20 minute recovery period isometric force had 
recovered to 72.4% (± 9.0 %) initial MVC for CFS, and 85.1 % (± 14.8 %) initial 
MVCforCON. 
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F.!£ure 5.2 Changes over tune m force output, expressed as % of 
initial MVC (error bars~ SEM) 
Central Fatigue 41 
Between groups Mann Whitney U tests showed no significant difference (p s; 
0.05). However, an exact p value of 0.08 suggests a trend that may require 
greater numbers to show as significant. Recovery rates may indicate a more rapid 
recovery in controls than CFS. Larger group numbers would be needed to 
establish significance in future studies. 
Peripheral muscular fatigue is indicated by the consistent decrement in MVC 
capacity. This is similar for both groups with no significant rJifferences, as shown 
in figure 5.2. Notice should be made of the apparent differences ~!ter recovt:ry. 
5.4 Perception ofExertion 
Figure 5.3, below, shows the development of perception of effort for both CFS and 
CON. Perceptions of effort are significantly different (p :5 0.05) between groups 
at start, mean 11.2 ± 0.6 (CFS) and 9.2 ± 0.5 (CON), and after 20% TOT, mean 
14.2 ± 0.5 (CFS) and 12.0 ± 0.7 (CON). Subsequently no significant difference is 
found between groups. 
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Figure 5.3 
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Differences between groups in RPE over task duration 
(error bars = SEM), * denotes significant. 
Wilcoxon signed ranks tests indicate that both groups showed a significant 
difference, within groups, from starting RPE during task (at p :> 0.05). 
5. 5 Evoked Potentials 
The size of the peak to peak amplitude of the MEP due to stimulation was 
followed and data normalised. MEP peak to peak amplitude (mV) and respective 
p values, for differences between groups, appear in table 5.3 below. The difference 
between CON and CFS groups towards the end of the protocol is not significant 
(at p value of0.05), with the exception of results at 80% TOT. 
However, the trends at 60% and 100% TOT show a clear divergence of responses. 
This is illustrated in Figure 5.4, where a divergence of the means is seen. If figure 
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5.4 is considered in conjunction with fatigue, as related to RPE (figure 5.3), 
different responses are observed for the same output in muscle force. 
Table 5.3 
Mean MEP (millivolts) for groups showing respective significance. Statistical 
significance determined using Mann Whitney U test. 
CON C FS exact p value 
start 8.3 5.5 0.5 2 
20% 9 3.8 0 .I I 
40% I 0.8 6.8 0 .I I 
60% I 0.9 5.8 0.0 8 
80% I 0. 7 4.8 0.0 3 
I 00% I 0 .I 6.4 0.0 8 
Wilcoxon matched-pairs signed-ranks test for start and finish values indicate no 
significant difference, within groups, from start and finish values (p >0.05), for 
either CFS or controls. The one exception was between groups at 80% TOT, 
where CFS group shows a slight drop (exact p = 0.03). 
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100 
Figure 5.4 Graph of mean MEP amplitude changes over time, error bars 
indicate SEM, * denotes significant difference. 
While not statistically significant the trend is to an apparently differing response, 
and as such warrants further exploration. 
5.6 Duration of Silent Period {SP) 
Duration ofthe EMG silent period {SP) following TMS was measured, in 
milliseconds (ms), from immediately after the stimulation trigger to when normal, 
asynchronous, EMG activity was detected. The changes in SP duration for 
controls, from start to 100% TOT, was found to be significant, Wilcoxon signed 
rank (exact p ~ 0.03), as was the SPat 60% TOT (p = 0.05). The SPat 80% TOT 
does not present as statistically significant however, an exact p value of0.07 
suggests a trend at the latter end of fatigue that requires further exploration. 
Central Fatigue 45 
A within groups assessment for SP duration in CFS was found to be not significant 
(at p s; 0.05), for any ofthe fatigue protocol. These are displayed graphically in 
figure 5.5 . 
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Figure 5.5 Mean SP duration responses (milliseconds) 
error bars= SEM, * denotes significant difference 
A between groups, Mann-Whitney U-Test, shows a significant difference during 
later part of protocol. Only starting values, as expected, and values at 20% TOT 
are found to be non-significant (p:::: 0.05). Thus, it is clear that responses ofCFS 
group are different to those of CON group over the course of the activity. 
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5. 7 Force changes during protocol. 
In order to compare force responses, a twitch/force ratio was calculated. This was 
done by measurh1g the force increase in response to TMS, and dividing by the base 
force being produced at 20% of initial MVC. At the final stage, 100% TOT, 
participants were required to produce a maximal effort, thus changing the force 
baseline. Figure 5.6 below, shows force and MEP responses to TMS at start and 
100% TOT for one participant (CFS 3). This participant showed some increase in 
MEP and some slight difference in SP duration. The force line appears to present 
as greater but it should be recalled that the baseline force has been altered as the 
final response is evoked under maximal contraction. 
Twitch force production in controls increased while the base remained constant. A 
change in the base, as at the end of fatigue where z. maximal effort was called for, 
produced a very different result. A within group evaluation shows significant 
differences (at p~ 0.05) from starting levels throughout protocol except for 100% 
TOT when the base force was altered. 
No significant changes to twitch ratio occurred within CFS group, at p~ 0.05 . 
This leads to a significant difference in response between the groups, Mann-
Whitney U-test (p ~ 0.05), for twitch ratios at 60% and 80% TOT. Responses at 
100% TOT are at maximal effort and therefore appear to respond differently. 
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lvfEP and force output for CFS 3, showing responses to TMS at 
start and end (l 00% TOT) of fatigue protocol. 
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Thus ratios may be useful in indicating altered responses to sustained levels of 
workload. The increasing force output due to TMS for controls seems to indicate 
a steady rise in response to greater stimulation. Of Interest is the decrease shown 
by both groups at I 00% TOT. This highlights the differences between responses 
to maximal efforts and sustained low level efforts. Both groups appear, therefore, 
to have similar responses to maximal output, whitt~ a differing response is apparent 
for sub-maximal workloads. 
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Figure 5.7 Twitch force ratio means, error bars indicate SEM 
The within group force twitch ratios from start to finish were, CON mean start 
0.49 (± 0.09), finish mean 0.27 (± 0.04), no significant difference (exact p value 
0.17); CFS mean start 0.48 (± 0.08), finish mean 0.32 (± 0.05), no significant 
difference (exact p value of0.09). 
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A between groups comparison show a significant difference in twitch force ratios 
at 60% and 80% TOT, (p ~ 0.05), this is shown in figure 5.7. Thus, sustained 
submaximal contractions appear to be producing a variation in response, yet 
subsequent maximal efforts appear to produce similar twitch force responses. 
Figure 5.7 also shows the apparent lack of change in twitch force for CFS group, 
while the CON group shows steady rise in twitch ratio with a subsequent drop at 
I 00% TOT. It should be noted that the final fifteen seconds was under conditions 
of a maximal contraction. 
CHAPTER SIX 
DISCUSSION 
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The main purpose of the study was to investigate differences in responses to 
fatigue between normal participants and those suffering from chronic fatigue 
syndrome (CFS). A problem in research into CFS is that prolonged inactivity, or 
reduced activity levels, leads to atrophy and impaired ability to perform exercise 
(Friman, 1977, p. 307; Friman, 1978, p. 107). In order to minimise such an 
effect the control group (CON) was matched for age, height, weight, and for a 
self reported activity index (AI), refer to appendix H. This allowed the 
comparison of what were relatively similar groups. If activity levels were 
similar, a similar response to the protocol could be expected and therefore any 
subsequent differences in response should be attributable to the independent 
variable, which was the pathology associated with CFS. 
6.1 Participant Comparisons 
Results for age, height, and weight, of groups showed no statistically significant 
differences, as shown in tables 5.1 and 5.2. This study observed a mean age of 
29.0 years (range 18.3 to 47.8 years). Other Australian studies, of individuals 
suffering from CFS, found mean ages of 34 years (Lloyd, Gandevia, & Hales, 
1991, p. 90), 33.7 years (Lloyd & Pender, 1992, p. 600), with a female to male 
ratio of 1.3: 1.0, and 31 years (Parker, Brukner & Rosier, 1996, p.271) with a 
female male ratio of 1.4: 1.0. Others, from the USA, have reported an 80% 
prevalence of females with a mean age of37.6 years (Gunn, Connell, & Randall, 
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1993, p.83). The high ratio offemales in some studies may have more to do 
with selection procedures and self presentation into studies. The small numbers 
in this study are considered responsible for providing an apparent imbalance with 
a female to male ratio of2.0:1.0. 
While the activity index (AI) showed no statistical significance, several CFS 
subjects had extremely low activity indices (AI< 10), refer to table 5.1. 
Problems associated with diagnosis of CFS and the ranges in AI may represent 
some outlier effect. Outlier effect may also be apparent due either to mis~ 
diagnosis, or early diagnosis, or to a good response to treatment. 
6.2 Strength Comparisons 
The initial maximum voluntary contractions (MVC) for both groups (tables 5 .I 
and 5.2) were not significantly different. This is as would be expected for 
groups matched for physical characteristics. The higher figures for CON (mean 
163.6 ± 19.5 N) over CFS (mean 123.5 ± 20.4 N) would seem to suggest some 
additional strength at the start. These differences may be more closely linked to 
disuse and normal atrophic responses to inactivity than to any pathological 
responses. General atrophic effects are known to be associated with disuse from 
inactivity linked to CFS and illnesses (Friman, 1978, p. I 07; Preedy, Smith, 
Salisbury, & Peters, 1993, p.725). Preedy et al. (1993) suggest that strength 
decrements may be linked to poor management of the disease rather than any 
pathological effect. For the purposes of this study the similarity between the 
groups was deemed to be .1cceptable. 
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Previous findings have also shown no significant difference to exist between 
controls and CFS patients in terms ofMVC or strength outputs (Lloyd, Hales, & 
Gandevia, 1988, p.1318; Lloyd, Gandevia, & Hales, 1991, p. 91; Preedy et al. 
1993, p. 725; Wessely&Edwards, 1993,9. 312). The present study, therefore, 
confinns such findings, that minor aberrations in strength are related to atrophy 
through non~use and inactivity rather than any intrinsic pathology. 
6.3 Duration of Test; Time on Task (TOT) 
The first hypothesis was that the symptoms offatigue experienced in CFS would 
lead to a reduced time to onset of fatigue identified by a reduced time on task 
(TOT). The results from the study found no significant difference between 
groups for TOT (mean CON 17.7 ± 3.5 minutes, mean CFS 14.5 ± 4.5 minutes). 
However, in viewing figure 5.1 it is noted that a large portion of the CFS group 
where incapable of sustaining sub~ maximal effort in excess often minutes. Thus, 
CFS participants showed a trend for shorter task times in spite of non~ statistical 
significance being presented. Future research, incorporating greater numbers of 
participants, may show a tighter range of TOT for both groups. 
A problem to be considered in suggesting such a trend is the validity of 
measuring the 20% MVC used as the target baseline. If one, or more, CFS 
participants did not achieve full MVC in the preliminary measures then the 20% 
target will have been below their actual level thus leading to an extended time to 
duration. One participant (CFS 2) attained a higher MVC after recovery than 
initial MVC. This was taken as an indication that initial MVC was not in fact 
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maximal and that, as a result, their sub-maximal target was suspect. This data 
was excluded from subsequent analysis of force production. However, based on 
force and RPE measures, it is assumed that others attained a maximal or near 
maximal effort. 
Muscle ischaemia is known to affect task duration (Fox et al. 1993, p. 172). Use 
of sub-maximal levels should alleviate any problems associated with occlusion 
and metabolite build up thus mimicking activities of daily living (ADL) and also 
minimising disruption due to physical impediments. Thus any differences infer a 
central fatigue effect. 
Those subjects exhibiting higher TOT were generally younger and more recently 
diagnosed. If early diagnosis and treatment is a factor in restricting the 
pathology of CFS this augments the need to develop a diagnostic procedure that 
will aid early detection. The small sample size may have distorted the data. This 
leads to the need to perform similar tests on larger populations in order to 
establish a clearer picture of fatigue time. Given similar fatigue times for the 
sub-maximal test it would be suspected that ADL for CFS and controls would 
also be similar. These were not assessed in this study but may need to be 
correlated with activity indicators in subsequent studies. 
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6.4 Responses to Stimulation 
The final hypothesis suggested that there would be an alteration in the motor 
responses to TMS during the fatigue protocol. MEP's, SP duration, and twitch 
force evoked by TMS as influenced by fatiguing exercise. Several studies have 
observed such responses to fatiguing protocols (Lloyd, Gandevia, & Hales, 
1991; Preedy et al. 1993) and to TMS (Brouwer & Packer, 1994, p. 1210). 
These provide data about nonnal responses enabling comparative assessments of 
both the control and CFS group. Evoked potentials, associated with cortical 
activity, appear to be a useful measure about the processing ofinfonnation 
(Wessely, 1993, p. 220). 
6.4.1 MEP changes 
The peak to peak summation ofEMG response was measured.as the MEP due 
to TMS. This is in effect an indicator of the level of cortical excitability and of 
activation of motor units. As the protocol continues it can be seen that CON 
show an increasing response to stimulation, see figure 5. 7. This supports 
previous reports where the fatigue resulted in an increase in cortical excitability 
in normal subjects (Maton, 1991; Brouwer & Packer, 1994, p. 1211). 
In the CFS groups no significant changes for MEP are found. The between 
groups test, Mann-Whitney U-test q.t p= 0.05, shows a significant difference 
between CFS and CON at 80% TOT. However, the differences between groups 
at 60% and 100% TOT present with an exact p value of0.08 suggesting a trend 
of difference is occurring. Thus it may be r.oncluded that the CFS group is 
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presenting with an altered response ofl\1EP due to stimulation. This implies that 
the enhanced corticomotor excitability observed in controls is not present in 
CFS. Brouwer and Packer (1994, p. 1211) found unstable responses in CFS. 
Such increased excitability in controls tends to result in an increased force 
production, as displayed by twitch force ratios, above baseJine tar&et. 
Such a change in MEP may indicate an increased response of the neural 
pathways, and subsequent enhanced responses from the muscle. As fatigue sets 
in and the peripheral mechanisms become strained, the control group's response 
increases. The CFS groups, on the other hand, seem to stabilise, or diminish 
somewhat. Thus it may be speculated that control and CFS participants are 
experiencing different responses under a condition of sub-maximal loading. 
These data seem to suggest an altered neurological response to the fatigue 
process, with CFS not apparently having the ability to modulate activity output 
through feedback into the CNS. Future research may confirm these findings that 
CFS has some pathological factor associated with the nerve pathways, or 
disrupted inhibitory mechanisms. 
6.4.2 Silent Period (SP) Duration 
The SP duration in response to TMS shows a distinct change over time for the 
CON. With a steady increase in SP duration over the task, statistical 
significance is seen at, and beyond, 60% TOT. Starting SP duration presented 
as a mean of 119 ± 15.7 milliseconds (ms), while at the end the mean was 186 ± 
20.9 ms. Figure 5.5 shows the clear and steady rise in SP duration over task. 
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Duration of the SP following evoked potential remained constant in the CFS 
group with no significant difference from starting SP. Mean SP at start was 107 
± 7.5 ms, and SPat end had a mean of 100 ± 7.7 ms (p > 0.05). This indicates 
that normal EMG activity of muscular contraction is resumed within the same 
time scale regardless of effort, fatigue or decreased capacity to maintain 
contraction. This suggests that inhibitory feedback from proprioceptors or Ia 
type interneurones, which is believed to modulate SP duration, is impaired. 
Increases in SP are associated with isometric contraction (Porter & Lemon, 
1993, p. 204), and usually signal inhibitory intemeurones in action. Normal SP 
increase is a reflection of an effect on inteme.urones. This may be triggered by 
proprioceptive mechanisms sending inhibitory signals to the CNS (Young, 
Triggs, & Gerstle, 1995, p. !290), or direct effect on the inhibitory 
interneurones. Thus, presynaptic and postsynaptic, or a combination of both 
inhibitory mechanisms may be in operation (Leis, Stetkarova, Beric, & Stokic, 
1995, p. 1468). 
The duration of SP following evoked potentials is regarded as indicative of the 
level of cortical inhibition. This may serve to prevent the muscle from over 
working or reaching a state of excessive fatigue. Altered cortical inhibition, 
during activity, is not observed in CFS. This, in turn, may cause an excessive 
response to activity leading to a state of excessive fatigue. 
A role of inhibition may be to prevent excessive activation through any one 
nerve pathway. Should such a mechanism be incapacitated in CFS it may 
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explain an increased response to fatigue, which would be expressly noticeable in 
recovery. Response to fatigue, in CFS, therefore may be showing a decreased 
neural feedback, from receptors or from a failure of inhibitory interneurones. 
6.4.3 Twitch Force Ratio Changes 
Even in maximal voluntary activity there is an amount of potential force that is 
not used (Wilson, G., 1995, p. 3). TMS is seen to elicit additional force over the 
baseline of facilitation. Thus twitch force is an indicator that additional force is 
available and that nerves are being activated to produce extra force. 
Twitch force production in controls increased significantly while the base force 
remained constant. Non~significant changes occurred in CFS. The increasing 
force output due to TMS for controls seems to indicate a steady rise ~n response 
to stimulation, as seen in MEP responses. The relative lack of change in CFS 
may indicate an altered response to neural input to the muscle. This may be due 
to reduced cortical excitability. Twitch force and maximal force are limited by 
neural feedback, such as muscle spindles and the golgi tendon organ (GTO) 
(Wilson, 1995, p. 3). Therefore, increases in twitch force ratios imply that 
inhibitory mechanisms have been overridden. rt can be seen that controls 
present a rise in twitch force, implying that inhibitory mechanisms are 
functioning in a normal manner. Such increases are not seen in CFS which may 
serve to indicate that inhibition is not working properly. The precise reason is 
still unclear. 
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Of interest is the decrease shown by both groups at 100% TOT. This highlights 
the differences between responses to maximal efforts and sustained low level 
efforts. Both groups appear, therefore, to have similar responses to maximal 
efforts, as has been noted in other studies (Lloyd et al. 1988; Lloyd et al. 1991; 
Wessely & Edwards, 1993). Little work appears to have been conducted on 
sustained sub-maximal contractions which was found to produce differing 
responses. Thus ratios may be useful in indicating altered responses to sustained 
levels of workload. 
6.4.4 Summary ofPhysiological Responses 
Abnormal or altered electrophysiological responses in CFS have been reported 
(Jamal & Hanson, 1985, p. 693; Brouwer & Packer, !994, p. 1212). The silent 
period (SP) following evoked potentials shows a clear difference between 
groups. Considering the same fatigue levels, strength and RPE measures, 
differences should be due to neurological responses to muscular activity linked 
to the condition prevalent. Differences in the SP duration lead to speculation 
that some failure of the normal inhibitory response, seeking to prevent overload 
of the muscle, is occurring. This may reflect a disruption of integration of 
proprioceptive mechanisms within the muscle or an inability of the CNS to 
process the responses optimally. Some findings suggest that !a inhibitory 
interneurones could be responsible for such inhibition (Porter & Lemon, 1993, p. 
205). 
Centro! Fatigue 59 
It would appear from the findings ofthis study that some neurological or 
neurophysiological differences are present as a result of the pathology associated 
with the CFS. While no differences are noted in initial MVC, the decrement, 
following recovery, points toward some impairment in physiological capacity of 
the muscle. Thus, some interplay between the neurological and physiological 
processes is clearly occurring. 
6.5 Perception of Effort 
The second hypothesis was that there would be an altered perception of exertion 
in CFS sufferers. The initial rates of perceived exertion, measured on the 
modified Borg scale, (Borg, 1982). were significantly different with CFS 
participants finding a 20% MVC to be more demanding than controls. Previous 
research suggestions, of elevated or exaggerated effort sense, are therefore 
confirmed (Lloyd et al. 1988; Brouwer & Packer, 1994, p. 1212) and support 
this hypothesis. However, difference between groups was only noted in the 
early stages, being identified at the start and at 20% TOT. Subsequently both 
groups followed the same rate of increase in line with increasing effort and 
showed no significant difference either within or between groups, refer to figure 
5.5. Therefore, during activity similar perceptions occur while at rest the CFS 
present with a perception that effort is harder. This trend may well imply that 
some homeostatic mechanism for the regulation of effort has been disrupted in 
CFS. If so. this would concur with findings from this study that some disruption 
has occurred at a cortical level. Investigation whether this is at a supraspinal or 
at an executive (cognitive) level is beyond the scope of this study. 
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Thus the same relative increase may be indicative of a similar sense of effort with 
a different starting point being the only major factor in perception. The finding 
of a different RPE base would seem to be logical given the lack of activity in 
CFS. Yet, it would also seem logical to expect low activity to be responsible for 
RPE levels in matched controls. It has yet to be determined if such perception is 
more closely associated with peripheral feedback mechanisms, or from alteration 
in the central (executive) processing of fatigue. Some changes in perfonnance 
are known to be attributed to altered sensory input (Friman, 1977, p. 307). 
During this task little difference was detected between CON and CPS. Starting 
RPE was different, but it should be borne in mind that this may be linked to 
disuse in management of the pathology rather than in response to the pathology 
itself(Preedy et al. 1993). A symptom ofCFS is heightened fatigue awareness 
while at rest (Lloyd et al. 1988, p. 1316), leading to suspicion of sensory input 
involvement. The results of this study suggest that differences seen during 
fatiguing exercise are not merely a perception but a real and valid result of the 
pathology associated with CFS. While RPE is a subjective measure (Preedy et 
al. 1993) , it still may have value for assessing CFS until some clear objective 
diagnostic measure is presented. 
6.6 Force Recovery 
The capacity to produce force, as indicated by changes in MVC as a result of the 
protocol, and subsequent recovery (figure 5.2), serve to indicate a consistent 
level of peripheral fatigue for both groups, both in force and time responses. 
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The results show that both groups suffered a similar decrement in muscle force 
capacity. Drop from initial MVC being, CON 53.0% (± 4.4%) and CFS 54.5% 
(± 6.2%). Subsequent differences should reflect a response of the central fatigue 
mechanisms involved. Differences between the groups should also reflect 
altered properties, or responses, of the central fatigue mechanisms. 
It has been shown that maximal isometric strength (MVC) is not affected by 
CFS (Lloyd eta!. 1988, p. 1321; Preedy eta!. !993). These findings were 
confirmed in this study by the similarity of responses in MVC pre-test, at the end 
of fatigue protocol, and post recovery, between CON and CFS. Initial MVC 
outputs and the MVC at end of task were similar. A disc~epancy appears 
following recovery, see figure 5.3. After twenty minutes rec,·wery CPS 
produced 72.4 (± 9.0)% of initial MVC while CON produced 85.1 (± 14.8)%. 
This was not significant. However, an exact p value of0.07 between groups 
shows some trend to recovery differences, which is also suggested by Lloyd et 
a!. ( 1988). While responses during activity were similar, responses following 
recovery may suggest that some recovery mechanism is associated with the 
pathology ofCFS. Should a different recovery time be required, for the same 
effort, this may limit ADL by restricting the time between doing different tasks. 
This possibility was beyond the scope of this study but warrants future 
investigation. 
CHAPTER SEVEN 
CONCLUSION AND RECOMMENDATIONS 
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One of the great difficulties in examining CFS as a disease is the widespread 
adaptation of various definitions for clinical evaluation. The CDC definition, 
applied in this study, is primarily a definition to help research in establishing a 
common ground (Holmes et al. 1988; Holmes, 1991; Lloyd & Pender, 1994). As 
such it may be oflittle benefit to the clinician treating the patient. Therefore, 
there is still a need for a "concise and universally accepted medical definition" 
(Preedy et al. 1993, p. 725). Objective indicators, as explored in this study, may 
prove beneficial, especially if correlated with results from other research. 
The first hypothesis was not confirmed by the results. It was seen that no 
alteration in the time to fatigue occurs. It would appear that time to fatigue is 
indicative of normal musculature response associated with peripheral fatigue. 
This would concur with previous studies suggesting that CFS has no apparent 
distinct peripheral pathoiO!,'Y (Lloyd et al. 1991; Preedy et al. 1993; Wessely & 
Edwards, 1993). While no significant difference was found, the range of times 
for CPS participants appears wider than for controls. Further, participants 
tended to present at the extremes of the range with half CFS showing endurance 
ofless than ten minutes. The endurance capacity in CPS requires further 
exploration before any conclusion can be drawn linking fatigue, endurance and 
pathology. 
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The second hypothesis was that an altered perception of effort would exist. This 
was shown with the CFS group presenting a greater perception of effort at start 
of task. Considering the matching of controls it would appear that the sense of 
effort is altered as a result ofCFS pathology. The interpreting of sensory and 
neural inputs may be impaired, or a cognitive process may be disrupted. Which 
ever the case perception of exertion requires clearer correlation with the central 
and peripheral components of fatigue. There has been speculation about a 
disturbed, centrally based, homeostatic mechanism (Maton, 1993; Ware, 1993, p. 
69; Kent-Braun, Sharma, Weiner, Massie, & Miller, 1993, p. 129). Disturbed 
rating of perceived exertion may reflect this, but such speculation requires more 
research. 
The final hypothesis was that altered motor response would be observed. 
Stimulation showed different responses between groups. Controls showed a 
steady increase in MEP amplitude and SP duration. These imply a functioning of 
inhibitory intemeurones. Inhibition of activation is a normal response, and 
increased inhibition, identified through increased silent period, is seen to be 
associated with extended isometric activities (Porter & Lemon, 1993, p. 203~ 
205). Inhibitory processes may serve to focus and direct neural activity in order 
to prevent overuse and thus damage. CFS participants showed a difference with 
no apparent increase in either MEP amplitude or SP duration. This implies that 
the normal inhibitory mechanisms are not operating optimally. 
The results from this study, in conjunction with previous findings seem to 
indicate a disrupted inhibitory mechanism for CFS. Both SP duration and MEP 
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increased in normals while no such change occurred in CFS. Therefore it may 
concluded that a normal increase in motorneurone excitability (Maton, 1993) is 
not seen in CFS. This leads to speculation on the mechanisms that might be 
disrupted for failure ofMEP and duration ofEMG silent period (SP) following 
stimulation. 
Disruption of inhibitory mechanisms may be responsible for the increased 
perception effort and associated fatigue at rest, seen in CFS. The homeostatic 
balance would appear to be disturbed and it may transpire that this 
neurophysioligical disruption has 'reset' the cortical determination of fatigue. 
This would be exhibited by excess fatigue :md a subsequent need for increased 
recovery times. Therefore it may be concluded that at sub-maximal activity 
levels an impaired central fatigue processing occurs in CFS. 
Chronic fatigue syndrome is a serious and complex illness characterised by 
incapacitating fatigue, neurological problems and a constellation of other 
debilitating symptoms. Traditional scientifiC medicine has tended to dichotomise 
the mind and body (Ware, 1993, p. 69). Perhaps in obse1ving central fatigue, a 
mechanism where the mind and body interface may be identified. Extension of 
the present study with greater numbers would serve to confirm the findings 
presented. A clearer picture of the endurance capacity of muscle in CFS, in 
conjunction with central fatigue measures, may determine where the root cause 
of the pathology lies. A continuation of an integrated approach to research is 
recommended in attempting to understand the pathology and aetiology of this 
debilitating disorder. 
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APPENDIX A 
Infonned Consent Sheets 
Central Fatigue in Overtraining and Chronic Fatigue Syndrome 
Informed Consent 
This study seeks to investigate the responses of the nervous system to muscle fatigue. 
All Procedures are nonwinvasive. 
One pair of recording electrodes will be taped to the biceps. These will measure muscle 
activity which will be fed into a computer. In order to examine the responses of the 
brain to fatiguing activity we will usc transcranial magnetic stimulation. A small 
magnetic coil will be positiont:rl above the skull, that part of the brain will be 
stimulated with a magnetic pulse. Each stimulus will be very short and is not painful, 
but some movements of the elbow flexor muscles will be noticed. Occasionally a 
tingling or tap on the head may be felt. 
During the session you will be asked to contract mnscles in the ann as hard as possible 
against a padded resistance for less than 5 seconds. You will also be asked to perfonn 
a sustained, low-level, isometric contraction of the biceps until fatigue. Your nonw 
dominant ann will be used to minimise disruption to regular activity. Some localised 
discomfort may be experienced but should be dissipated with a few days. The whole 
procedure will take between I and 2 hours. 
If you have any doubts or questions pleased ask the staff on hand or contact Peter Hope 
(Principal Investigator) on 400 5054, or Dr. Paul Sacco (Research Supervisor) on 400 
5642. 
All data collected will be coded to ensure your personal confidentiality. No infmmation 
will be reported in a manner that can allow you to be identified from the results. Your 
permission to pcrfom1 this testing is voluntary. You are free to stop the test or 
withdraw at any point. 
Name 
I have read the informed consent and any questions have been 
answered to my satisfaction. The tests and associated risks 
have been fully explained to me. I agree to participate in this 
study voluntarily realising that I may withdraw at any time. To 
the best of my knowledge I am not pregnant, do not have 
raised blood pressure or any heart problems and have no metal 
plates in my head 
Signature ......... , ................................ .. 
Witness ................................... . Date 
APPENDIX B 
Transcranial Magnetic Stimulation 
Transcranial Magnetic Stimulation 
TMS uses a large pulse magnetic field to induce currents within the body. Theses 
pulsed magnetic fields can stimulate both the central and peripheral nervous systems. 
According to the Jaws of electromagnetism, a time varying magnetic field will induce an 
electrical field in any specified loop in its vicinity. TMS causes changes in the structural 
integrity of projections of the corticospinal pathways in humans. These responses reflect 
the output of the stimulated population of cortical neuroncs to motorneuroncs. In 
neurological disorders there may be abnormal excitability of the motor pathways. 
TMS applied over the scalp of the relaxed individual activates contralateral muscles in a 
distinct pattern apparent from their order of recruitment and amplitudes of the muscle 
responses. The upper limbs, hand and foreann muscle have the lowest thresholds for 
activation, hence the largest compound EPSP's are produced in the motor neurones 
innervating intrinsic hand muscles. 
Magnetic stimulation is virtually painless, with minor discomfort due to the evoked 
muscle contraction. There have been no deleterious effects in investigations using TMS. 
There is a small amount ofthennal energy deposited, equivalent to approximately on per 
cent of that generated by nonnal metabolism in the brain. 
There are many advantages to the usc of TMS. Theses include the ability to penetrate 
all human tissue without attenuation, hence advantageous when stimulating regions 
below layers of bone. It does not cause large electrical fields at the surface, nor docs it 
require physical or electrical contact with the body. No skin preparation or the removal 
of clothing is necessary at the stimulation site. It is blind to smearing effects of extra 
cerebral layers thereby allowing a more precise measurement of the threshold for 
excitation of motor evoked potentials, and is able to influence endogenous processes of 
movement preparation cxtemally without dismpting the conscious perception of volition. 
Disadvantages ofTMS include the equipment's relative bulkiness. The stimulation rate 
is relatively slow, with the site of stimulation not well defined. 
APPENDIX C 
Borg Scale - Perceived Exertion 
SCALE FOR RATING PERCEIVED EXERTION 
6. 
7. very, very light 
8. 
9. very light 
10. 
11. fairly light 
12. 
13. some what hard 
14. 
15. hard 
16. 
17. very hard 
18. 
19. vety, very hard 
20. 
The Borg scale of perceived exertion (Borg, 1972), is widely used in the fonn of 
a chart placed in front of participants . lis key benefits is that it allows them to 
indicate how they perceive their present state of 'effort sense' using a single 
number. This minimises distraction and also allows for standardised 
comparisons across time and between individuals 
APPENDIX D 
Symptoms Associated With OTS 
Factors attributed to excessive exercise stress : 
The symptoms of overtraining (OTS) 
BIQCHEMICAL/HAEMATOLOGICAL 
Altered cyclic adenosine monophosphate 
metabolism 
Decreased hacmatocrit 
Decreased haemoglobin (anaemia) 
Decreased iron absorption 
Decreased red blood cells 
Decreased scmm ferritin 
Decreased serum iron 
Elevated 3~methylhistidine 
CARDIORESPIRATORY FUNCTION 
Abnormal rate in heart rate during 
standard workout 
Breast pain 
Consciousness of heart rate 
Deere ased maximum heart rate 
Der,;:eased morning heart rate 
Decreased vital capacity 
Disturbed feeling around the heart 
Elevated systolic blood pressure 
Heart discomfort on slight exertion 
Higher heart rate at standard workload 
Impeded respiration and subcostal 
aching during normal activity 
Increased difference bet\vccn lying and 
standing heart rate 
Elevated Ketosteroids in urine 
Increased iron loss 
Increased urea concentrations 
Increased uric acid production 
Low resting haptoglobin 
Lowered TIBC 
Negative nitrogen balance 
(NUMBER= 15) 
Increased frequency and lowered 
volume of pulse 
Increased frequency of respiration 
Increased heart rate (5-10 beats from 
nonnal) 
Increased quotient of heart volume and 
maximum oxygen pulse 
Marked palpitation during exercise 
Quick rctum of heart rate to pre-
exercise levels 
Shortness of breath 
Slight pain in pericardia! areas 
Slower recovery of heart rate following 
standard load 
(NUMBER= 24) 
DRINKING/ NUTRITIONAL DISORDERS 
Anorexia nervos11 
Bulemia 
Constipation 
Decreased evening post workout weight 
Digestive disturbance 
Feels thirsty/ chronic dehydration 
Gastrointestinal disturbances 
HORMONAL 
Adrenal gland sensitivity 
Adrenal hypofunction 
Adrenal overstimulation 
Adrenocortical insufficiency 
Ammerllmreal oligomenhorea 
Decreased adrenalin at maximal 
workloads 
Decreased adrenalin at standard 
submaximal workloads 
Decreased bone mineral content 
Decreased exercise induced elevation of 
catecholamines 
Decreased noradrenalin at standard 
submaximal workloads 
INFECTIOUS DISEASE 
Adrenal gland swelling 
Altered glutamine metabolism 
Altered interferon metabolism 
Aseptic meningitis 
Bacterial infection 
Bacterial meningitis 
Decreased functional activity of neutrophil 
adhcrenec 
Inadequate diet 
Increased fluid intake in the evening 
Loss of appetite 
Mineral depletion 
Vitamin E deficiency 
(NUMBER~ 12) 
Decreased ration of testosterone to cortisol 
Delayed menarche 
Depressed prolactin 
Depressed serum testosterone 
Dishannonic honnonal control 
Elevated serum cortisol 
Elevated sex honnone binding globin 
Hypothalmie dysfunction 
Impaired GH, ACTH, Cortisol and PRL 
response to insulin induced hypoglycaemia 
Parasympathetic dominance 
Pituitary gland insufficiency 
Thyroid hyperfunction 
(NUMBER~ 23) 
Decreased immunoglobulin (serum) 
Decreased neutrophil bacteriocidal 
activity 
Decreased neutrophil mediated oxygen 
radical response 
Decreased nonspecific i~munity 
Decreased salivary JgA 
Depressed immune function 
Flu~like illnesses 
Frequent or persistent colds 
Glandular fever 
Heart failure 
Increased antistreptolysin~O titre 
Increased blood eosinophil count 
Increased immunoglobulin 
Increased noxiousness of coxackie B3 
vims 
Increased susceptibility to and severity of 
polio 
Increased susceptibility to hepatitis 
Inc.reased susceptibility to illness/ colds/ 
allergies 
Lymph glands atrophy 
Minor scratches heal slowly 
More days off through illness 
More frequent and severe upper 
respiratory tract infection 
MUSCULOSKELETAL COMPLAINT 
Decreased circumferential measures in 
exercised limbs 
.Elevated C~reactive protein 
Elevated, CPK, LDH, SGOT 
Increased incident of injury/ overexercise 
injury 
Joint pain 
Muscle damage 
Muscle soreness/ tenderness 
Muscle stiffi1ess 
Myocarditis 
One day colds 
Pericarditis 
Re~activation of Herpes viral infection 
Reduced response to mytogens 
Severely debilitating states 
Sinusitis 
Skin rashes 
Skin sepsis 
Sore thro<~.ts 
Suffer head colds/ allergic reactions 
Swelling of lymph glands 
Thymus gland wittles 
Tracheitis 
Tracheobronchitis 
Unconfirmed glandular fever 
Worsen disease 
Worsening of hepatitis 
(NUMBER= 49) 
Myoglobinaemia 
Myoglobinuria 
Necrotic fibres 
Periosteal complaints 
Rhabdomyolysis 
Stress fractures 
Tendency towards pulled muscles 
Tendinosotic complaints 
Unaligned Z~lincs 
(NUMBER = 17) 
PERFO~CERELATED 
Career terminated 
Chronic fatigue 
Decreased ability to sprint 
Decreased maximum work capacity 
Decreased muscular strength 
Decreased performance in training/ 
competition 
Decreased time trail performance 
Decreases in the level of speed and 
endurance 
Desire to quit during competition 
PHYSICAL 
Backaches 
Change in pallor of the skin 
Cold feet and hands 
Death 
Decreased body fat 
Eyestrain 
Haemolysis 
PHYSIOLOGICAL 
Acute oligururic renal failure 
Decreased maximal lactate production 
Decreased maximal oxygen consumption 
Depressed insulin glycogen concentration 
Depresse.! lactate levels at maximal 
workloads 
Elevated basal metabolic rate 
Elevated blood sugar levels 
Failure to improve muscular strength 
Fatigue lasts longer than usual 
Feelings ofheaviness 
Inability to meet perfonnance standard 
criteria 
Increased fatigue during exercise/rest 
Loss of joy of competition 
Recovery prolonged 
Reduced toleration of loading 
(NUMBER = 17) 
Headaches 
Nausea 
Peptic ulcers 
Physical distress 
Profuse perspiration 
Spastic colon 
(NUMBER= 13) 
Flat glucose tolerance curves 
Free radical damage to enzymes, 
111embranes, etc. 
Free radical mediated red cell lysis 
Lean tissue loss 
Low fasting blood glucose 
Mild hypoglycaemia 
(NUMBER= 13) 
PSYCHOLOGICAL 
Alienation fonn others 
Antipathy for training sites 
Appears nervous/feels nervous/ 
increased anxiety 
Athlete endeavours to spare energy/ 
avoid physical effort 
Athlete feels alienated 
Athlete looks drawn, sallow and 
depressed 
Become unduly upset at trivial incidents 
Becomes aggressive 
Becomes cynical 
Changes in behaviour 
Changes in personality 
Decreased ability to narrow 
concentration 
Decreased capacity to deal with large 
amounts of infommtion 
Decreased concentration 
Decreased energy 
Decreased positive affect expression 
Decreased self esteem/worsening 
feelings of self 
Decreased tolerance to stress 
Decreased vigour 
Depression, of clinical signif1cance 
Depressive illlnnnour 
Difficulty in concentrating at training 
Difficulty in concentrating at work 
Discomfort when training 
Doesn't feel nny better after a few days 
rest 
Dramatic changes in values and beliefs 
eg: poor weather, b8.d officials, etc. 
Emotional instability 
Exaggerated negative influence of 
external factors 
Expressions of or feelings of increased 
anger 
Fear of competition 
Feeling of being locked into routines 
Feelings of anticlimax and boredom 
Feelings of depression 
Feelings of frustration 
Feelings of heaviness 
Feelings ofheaviness 
Feelings of helplessness 
Feelings of inadequacy 
Feelings 0flistlessness 
Feelings of resentment towards the 
whole training process 
Feelings of tension 
Feelings oftiredness/drmvsincss 
Feels phlegmatic 
General apathy 
Gives up when the going gets tough 
Growing feelings of incompetence 
Hesitant to train/ loss of joy in 
competition/loss of thirst for 
competition 
Impaired academic pcrfonnance 
Increased confusion 
Increased consumption of coffee, 
tobacco, alcohol 
Increased excitability 
Increased in emotional and behavioural 
impulsivity 
Increased internal and e:\.1ernal 
distractability 
Increased irritability 
Increased perceived effort 
Increased restlessness 
Irascible 
Isolate self from team mates/coach 
Isolates self emotionally 
Lack of fighting power 
Lack of initiative 
Lethargy 
Letting minor stresses bother 
Loses confidence 
Loss of interest in training 
Loss of interest in work 
Loss of libido 
Loss of purpose and energy for living 
Miserable 
Motivational imbalance/loss of 
enthusiasm 
Negative changes in frame of mind 
No dr.sire to practice or improve 
SENSORIMOTOR PERFORMANCE 
Actions slower and less precise 
Decreased aerobic cfficie, 1cy 
Decreased n.echanical efficiency/ 
Decreased amplitude of movement 
Decreased nervous conductinn 
Dccrca.>cd reaction time 
Exaggerated postural hypotension 
Exaggerated tdlcxcs 
General dumsincss 
Not eating well 
Not enjoying life generally 
Peevish 
Perceived low achievement 
perceived sense of loss of control 
Progressive loss of idealism 
Psychic unrest 
Quarrelsome/provocative behaviour 
Rundown feeling 
Sense of insecurity 
Sensitive to criticism 
-•tVIronmental and 
~.:motional stress 
Sluggishness 
Sluggislmess that persists longer than 
24 hours 
Slump in morale 
Suppressed moods 
Unable to get ready for practice 
Unable to relax 
Unreasonable complaints 
(NUMBER ~ 91) 
Hypersensitivity to sensory stimulation 
of pain or noise with exaggerated 
responses to these stimuli 
Inconsistency in perfonning rhytlm1ical 
movements 
Increased distractability 
Increased hear rate at a given workload 
Increased muscle tension 
lnJrcascd ventilation at a given 
workload 
Lack of stability 
Lengthening of decision time 
Loss of co·ordination 
Loss of muscle tone 
Poor muscular control and balance 
Psychomotor retardation 
Reappearance of mistakes already 
corrected 
SLEEP RELATED 
Awake frequently at night 
Decreased hours of sleep 
Insomnia 
Night sweats 
Reduced capacity of differentiation and 
correcting technical faults 
Reduced or lowered critical flicker-
fusion frequency 
Slowing of sensory motor perfonnance 
Tremors hands and eyelids 
(NUMBER = 25) 
Sleep disturbance 
Sleep not refreshing 
Trouble falling asleep 
(NUMBER=?) 
From Fry, Morton, & Keast (199lc, p. 48). Full listing available from authors. 
APPENDIX E 
Normalised Data 
normalised portion of time start 20% 40% 60% 80% 100% 
CON 1 SP Duration (ms) 97 104 130 119 98 139 
CON1 MEP Amplitude (mV) 17.48 18.43 19.03 18.93 19.90 1S.64 
CON1 Twitch Force (newtons) 14.2 1S.2 18.4 24.2 2S.2 24.2 
CON1 base force 43.8 43.8 43.8 43.8 43.8 148.3 
CON1 twitch ratio 0.3 0.3 0.4 0.6 0.6 0.2 
CON1 RPE (O.S min) 11 1S 18 20 20 20 
CON2 SP Duration (ms) 89 99 13S 120 123 169 
CON2 MEP Amplitude (mV) 11.SS 13.27 13.42 13.98 13.90 11.98 
CON2 Twitch Force (newtons) 22.6 2S.8 26.8 26.3 24.7 11.6 
CON2 base force 27.4 27.4 27.4 27.4 27.4 SS.9 
CON2 twitch ratio 0.8 0.9 1.0 1.0 0.9 0.2 
CON2 RPE (O.S min) 9 11 13 1S 16 18 
CON3 SP Duration (ms) 122 171 1SO 137 148 12S 
CON3 MEP Amplitude (mV) 4.S6 7.7S 8.38 7.66 7.09 9.76 
CON3 Twitch Force (newtons) 10.0 12.S 11.0 22.S 13.8 34.2 
CON3 base force 37.7 37.7 37.7 37.7 37.7 9S.8 
CON3 twitch ratio 0.3 0.3 0.3 0.6 0.4 0.4 
CON3 RPE (O.S min) 10 11 12 17 20 20 
CON4 SP Duration (ms) 189 148 149 179 16S 208 
CON4 MEP Amplitude (mV) 10.2S 8.12 13.28 11.93 11.81 11.34 
CON4 Twitch Force (newtons) 17.3 16.8 25.2 43.1 S1.5 31.0 
CON4 base force S0.7 50.7 50.7 50.7 S0.7 86.9 
CON4 twitch ratio 0.3 0.3 o.s 0.9 1.0 0.4 
CON4 RPE (O.S min) 8 10 13 16 19 20 
CONS SP Duration (ms) 128 164 184 193 190 214 
CONS MEP Amplitude (mV) 1.59 2.79 2.99 2.90 3.40 4.45 
CONS Twitch Force (newtons) 15.2 16.3 20.5 22.6 23.7 8.4 
CONS base force 21.6 21.6 21.6 21.6 21.6 48.2 
CONS twitch ratio 0.7 0.8 0.9 1.0 1.1 0.2 
CONS RPE (O.S min) 8 13 17 19 20 20 
CONS SP Duration (ms) 87 109 127 126 170 262 
CONS MEP Amplitude (mV) 4.12 3.71 7.SS 9.72 8.38 7.4S 
CONS Twitch Force (newtons) 12.1 19.4 22.1 26.8 35.2 1S.8 
CONS base force 24.7 24.7 24.7 24.7 24.7 48.2 
CONS twitch ratio o.s 0.8 0.9 1.1 1.4 0.3 
CONS RPE (O.S min) 9 12 17 19 20 20 
normalised portion of time start 20% 40% 60% 80% 100% 
CFS1 SP Duration (ms) 95 65 97 77 89 86 
CFS1 MEP Amplitude (mV) 5.32 1.86 6.40 0.41 2.57 9.53 
CFS1 Twitch Force (newtons) 13.1 3.7 8.4 6.8 3.7 12.6 
CFS1 base force 22.2 22.2 22.2 22.2 22.2 41.9 
CFS1 twitch ratio 0.6 0.2 0.4 0.3 0.2 0.3 
CFS1 RPE (0.5 min) 14 16 18 19 20 20 
CFS2 SP Duration {ms) 106 107 90 111 133 79 
CFS2 MEP Amplitude (mV) 9.87 5.31 9.94 8.69 5.51 2.70 
CFS2 Twitch Force (newtons) 14.7 14.2 15.2 14.2 10.5 23.1 
CFS2 base force 17.4 17.4 17.4 17.4 17.4 70.1 
CFS2 twitch ratio 0.8 0.8 0.9 0.8 0.6 0.3 
CFS2 RPE (0.5 min) 10 13 17 19 20 20 
CFS3 SP Duration (ms) 113 103 114 125 124 125 
CFS3 MEP Amplitude (mV) 2.87 3.37 5.03 4.67 6.26 5.68 
CFS3 Twitch Force (newtons) 6.8 8.4 9.5 11.6 13.7 15.2 
CFS3 base force 18.8 18.8 18.8 18.8 18.8 28.3 
CFS3 twitch ratio 0.4 0.4 0.5 0.6 0.7 0.5 
CFS3 RPE (0.5 min) 11 14 17 18 19 20 
CFS4 SP Duration (ms) 101 106 105 103 113 107 
CFS4 MEP Amplitude (mV) 3.73 4.19 6.85 9.26 2.82 10.12 
CFS4 Twitch Force (newtons) 19.4 22.6 24.2 28.9 28.4 34.2 
CFS4 base force 45.1 45.1 45.1 45.1 45.1 110 
CFS4 twitch ratio 0.4 0.5 0.5 0.6 0.6 0.3 
CFS4 RPE (0.5 min) 11 14 16 17 19 20 
CFS5 SP Duration (ms) 140 138 125 109 108 115 
CFS5 MEP Amplitude (mV) 6.22 4.62 7.46 7.00 6.78 5.79 
CFS5 Twitch Force (newtons) 7.9 7.9 10.0 8.4 8.4 13.7 
CFS5 base force 21.8 21.8 21.8 21.8 21.8 51.6 
CFS5 twitch ratio 0.4 0.4 0.5 0.4 0.4 0.3 
CFS5 RPE (0.5 min) 11 15 18 20 20 20 
CFS6 SP Duration (ms) 88 99 122 97 85 85 
CFS6 MEP Amplitude (mV) 5.18 3.51 5.18 4.89 4.83 4.37 
CFS6 Twitch Force (newtons) 7.4 5.3 8.4 7.4 6.8 12.6 
CFS6 base force 26.2 26.2 26.2 26.2 26.2 77 
CFS6 twitch ratio 0.3 0.2 0.3 0.3 0.3 0.2 
CFS6 RPE (0.5 min) 10 13 15 18 20 20 
CON MEANSP 119 133 146 146 149 186 
SEM 15.7 13.2 8.6 13.1 13.7 20.9 
MEAN MEP 8.3 9.0 10.8 10.9 10.7 10.1 
SEM 2.4 2.4 2.3 2.2 2.4 1.6 
MEAN Twitch Force 15.2 17.7 20.7 27.6 29.0 21.0 
SEM 1.8 1.9 2.3 3.2 5.3 4.3 
MEAN base force 34.3 34.3 34.3 34.3 34.3 80.7 
SEM 4.7 4.7 4.7 4.7 4.7 15.8 
MEAN Twitch Ratio 0.49 0.58 0.67 0.85 0.90 0.27 
SEM 0.09 0.11 0.12 0.09 0.15 0.04 
MEAN RPE 9.2 12.0 15.0 17.7 19.2 19.7 
SEM 0.5 0.7 1.1 0.8 0.7 0.3 
CFS MEANSP 107 103 109 104 109 100 
SEM 7.5 9.5 5.7 6.6 7.7 7.7 
MEAN MEP 5.5 3.8 6.8 5.8 4.8 6.4 
SEM 1.0 0.5 0.7 1.3 0.7 1.2 
MEAN Twitch Force 11.6 10.4 12.6 12.9 11.9 18.6 
SEM 2.1 2.9 2.5 3.4 3.6 3.5 
MEAN base force 25.3 25.3 25.3 25.3 25.3 63.2 
SEM 4.2 4.2 4.2 4.2 4.2 11.9 
MEAN Twitch Ratio 0.48 0.42 0.51 0.51 0.46 0.32 
SEM 0.08 0.10 0.08 0.09 0.09 0.05 
MEAN RPE 11.2 14.2 16.8 18.5 19.7 20.0 
SEM 0.6 0.5 0.5 0.4 0.2 0.0 
APPENDIX F 
Statistical Analysis 
Combined 
N Mean Std Dev Minimum 
AGE 12 28.95000 11.12855 18.25 
AI 12 38.41667 25.85082 6.00 
MVC PRE 12 141.50000 47.19688 80.00 
SEX 12 1. 33333 .49237 1.00 
TASKTIME 12 16.08333 9.49122 6.00 
GROUP 12 1. 50000 . 52223 1.00 
control Group 
Ntunber of valid observations (listwise) "" 6.00 
variable TOT time on task 
Mean 17.667 
Std Dev 8.548 
Kurtosis -2.286 
Skewness . 408 
Range 19.000 
Maxirnwn 29.00 
Valid observations -
Variable AGE 
Mean 
Std Dev 
Kurtosis 
Skewness 
Range 
Maximum 
26.642 
9.331 
-1. BOO 
.915 
20.100 
39.40 
Valid observations -
6 
6 
Variable AI activity index 
Mean 
std Dev 
Kurtosis 
Skewness 
Range 
Maximum 
48.000 
21.014 
.559 
-1.167 
52.000 
64.00 
Valid observations -
Variable MVC mvo 
Mean 160.167 
Std Dev 39.148 
Kurtosis -2. 114 
Skewness -.016 
Range 95. 000 
Maximum 205.00 
Valid observations -
6 
pre-fatigue 
6 
S.E. Mean 
Variance 
S.E. Kurt 
S.E. Skew 
Minimum 
3. 4 90 
73.067 
1. 741 
.845 
10.00 
Missing observations -
S.E. Mean 
Variance 
S.E. Kurt 
S.E. Skew 
Minimum 
3.809 
87.068 
1.741 
.845 
19.30 
Missing observations -
S.E. Mean 
variance 
S.E. Kurt 
S.E. Skew 
Minimum 
8.579 
441.600 
1. 741 
.845 
12.00 
Missing observations -
S.E. Mean 15.982 
Variance 1532.567 
S.E. Kurt 1.741 
S.E. Skew .845 
Minimum 110.00 
Missing observations -
Maximum 
47.75 
64.00 
221.00 
2.00 
32.00 
2.00 
0 
0 
0 
0 
CFS grOUF 
Number of valid observations (listtvise) = 6.00 
variable TOT time on task 
Mean 
Std Dev 
Kurtosis 
Skewness 
Rano;e 
Maximum 
14.500 
10.913 
-.609 
1.078 
26.000 
32.00 
Valid observations - 6 
Variable AI activity index 
Mean 
Std Dev 
Kurtosis 
skewness 
Range 
Maximum 
28.833 
28.428 
-2.098 
.669 
58.000 
64.00 
Valid observations -
Variable AGE 
Mean 
Std Dev 
Kurtosis 
Skewness 
Range 
Maximum 
31.258 
13.138 
-1.876 
.546 
29.500 
47.75 
Valid observations -
Variable MVC mvc 
Mean 122.833 
std Dev 50.317 
Kurtosis 4. 353 
Skewness 1. 970 
Range 141.000 
Maximum 221.00 
Valid observations -
6 
6 
pre-fatigue 
6 
S.E. Mean 
Variance 
S.E. Kurt 
S.E. Skew 
Minimum 
4. 455 
119.100 
1. 741 
.845 
6.00 
Missing observations -
S.E. Mean 
Variance 
S.E. Kurt 
S.E. Skew 
Minimum 
11.606 
808.167 
1. 741 
.845 
6.00 
Missing observations -
S.E. Mean 
Variance 
S.E. Kurt 
S.E. Skew 
Minimum 
5.363 
172.601 
1. 741 
.845 
18.25 
Missing observations -
S.E. Mean 20.542 
Variance 2531.767 
S.F.:. Kurt 1. 741 
S.E. Skew . 845 
Minimum 80.00 
Missing observution.s -
6 
6 
6 
6 
N Mean Std Dev Minimum Maximum 
MVC PRE 
TASKTIME 
GROUP 
12 
12 
12 
141.50000 
16.08333 
1.50000 
47.19688 
9.49122 
.52223 
- - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
MVC PRE 
by GRoiJp 
Mean Rank 
4.83 
8.17 
Cases 
6 
6 
12 
GROUP ~ 1.00 CFS 
GROUP 2.00 control 
Total 
Exact 
80.00 
6.00 
1.00 
221.00 
32.00 
2.00 
Corrected for ties 
- -
by 
u 
8.0 
- - Mann-Whitney 
TASKTIME 
GROUP 
Mean Rank 
5.58 
7.42 
u 
12.5 
time on 
cases 
6 
6 
12 
w 
29.0 
2-Tailed P 
.1320 
z 
-1.6041 
2-Tailed P 
.1087 
U - Wilcoxon Rank sum W Test 
task 
GROUP 
GROUP 
Total 
w 
33.5 
= 1.00 CFS 
2.00 control 
Exact 
2-Tailed P 
.3939 
corrected for ties 
Z 2-Tailed P 
-.8854 .3760 
- - - - - Mann-Whitney U - Wilcoxon Rank sum w Test 
MVC FAT MVC at end of fatigue protocol 
by GROUP 
Mean Rank Cases 
5.67 
7.33 
6 
6 
12 
GROUP 
GROUP 
Total 
" 
1.00 CFS 
2.00 control 
Exact Corrected for ties 
w 2-Tailed p U Z 2-Tailed P 
34.0 .4848 13.0 -.8006 .4233 
- - - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
MVC PRE 
by GROUP 
Mean Rank Cases 
4.83 
8.17 
6 
6 
12 
GROUP 
GROUP 
Total 
1.00 CFS 
" 
2.00 control 
Exact Corrected for ties 
w 2-Tailed p U Z 2-Tailed P 
29.0 .1320 8.0 -1.6041 .1087 
- - - - - Mann-Whitney U ·- Wilcoxon Rank Sum W Test 
MVC_REC MVC post recovery 
by GROUP 
Mean Rank Cases 
4.33 6 GROUP 
" 
1. 00 CFS 
8.00 5 GROUP 
" 
2. 00 control 
11 Total 
Exact 
u w 2-Tailed p 
corrected for ties 
z 2-Tailed p 
5.0 40.0 .0823 -1.8257 . 0679 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
MVCDROP % drop MVC due to fatigue protocol 
by GROUP 
Mean Rank 
5.58 
7.42 
cases 
6 GROUP 
6 GROUP 
12 Total 
1. 00 CFS 
2. 00 control 
Corrected for ties 
Z 2-Tailed P u 
12.5 
w 
33.5 
Exact 
2-Tailed P 
.3939 -.8838 .3768 
- - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
STARTRPE RPE start fatigue 
by GROUP 
Mean Rank Cases 
8.75 6 GROUP 1.00 CFS 
4.25 6 GROUP 2 .00 control 
12 Total 
Exact 
u w 2-Tailed p 
corrected for ties 
z 2-Tailed p 
q • 5 52,5 .0260 -2.2249 .0261 
N Mean Std Dev Minimwn Maximum 
RATIOlOO 12 .30000 .09535 .20 .so 
RATI020 12 .71667 .76257 .20 3.00 
RATI040 12 • 59167 .25746 .30 1.00 
RATI060 12 .68333 .27579 .30 1.10 
RATIOBO 12 .68333 .35633 .20 1.40 
RATIO ST 12 .48333 .19462 .30 .so 
REP100 12 19.83333 .57735 18.00 20.00 
RPE20 12 13.08333 1. 83196 10.00 16.00 
RPE40 12 15.91667 2.15146 12.00 18.00 
RPE60 12 18.08333 1.56428 15.00 20.00 
RPESO 12 19.41667 1.16450 16.00 20.00 
f!.PESTART 12 10.16667 1. 64225 8.00 14.00 
SPlOO 12 142.91667 58.40370 79.00 262.00 
SP20 12 117./5000 30.92844 65.00 171.00 
SP40 12 127.33334 25.73407 90.00 184.00 
SP60 12 124.66666 32.70900 77.00 193.00 
SP80 12 128.83333 33.47953 85.00 190.00 
SPSTART 12 112.91666 29.32718 87.00 189.00 
GROUP 12 1.50000 .52223 1.00 2.00 
- - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
RATIOlOO 
by GROUP 
Mean Rank 
7.08 
5. 92 
u 
14.5 
twitch ratio at 100% 
Cases 
6 
6 
12 
GROUP 
GROUP 
Total 
w 
42.5 
" 
1.00 CFS 
2.00 control 
Exact 
2-Tailed P 
. 5887 
corrected for ties 
Z 2-Tailed P 
-.5935 .5528 
- - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
RATI020 
by GROUP 
Mean Rank 
5.00 
8.00 
u 
9. 0 
twitch ratio at 20% 
Cases 
6 GROUP 
6 GROUP 
12 Total 
w 
30.0 
1. 00 CFS 
2.00 control 
Exact 
2-Tailed P 
.1797 
corrected for ties 
Z 2-Tailed P 
-1.4591 .1445 
- - - Mann-Whitney U - Wilcoxon Rank sum W Test 
RATI040 
by GROUP 
Nean Rank 
5.75 
7. 25 
u 
13.5 
twitch ratio at 40% 
Cases 
6 GROUP 
6 GROUP 
12 Total 
w 
34.5 
1. 00 CFS 
2.00 control 
Exact 
2-'J'ailed P 
.4848 
Corrected for ties 
Z 2-Tailed P 
-.7416 .4593 
- - - - Mann-Whitney u - Wilcoxon Rank sum w rest 
RATI060 twitch ratioa at 60% 
by GROUP 
Mean Rank Cases 
4.17 
8.83 
6 GROUP 
6 GROUP 
12 Total 
1. 00 CFS 
2.00 control 
Corrected for ties 
Z 2-Tailed P u 
4.0 
w 
25.0 
Exact 
2-Tailed P 
.0260 -2.2904 .0220 
- - - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
RATI080 
by GROUP 
Mean Rank 
4.42 
8.58 
twitch ratio at 80% 
Cases 
6 GROUP 
6 GROUP 
12 Total 
1.00 CFS 
2, 00 control 
corrected for ties 
Z 2-Tai1ed P u 
5.5 
w 
26.5 
Exact 
2-Tailed P 
.0411 -2.0193 .0435 
- - - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
RATIO ST twitch ratio at start 
by GROUP-
Mean Rank 
6.83 
6.17 
Cases 
6 GROUP 
6 GROUP 
12 Total 
1. 00 CFS 
2.00 control 
Corrected for ties 
Z 2-Tailed P u 
16.0 
w 
41.0 
Exact 
2-Tailed P 
.8182 -.3290 .7422 
- - - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
REPlOO RPE at 100% TOT 
by GROUP 
Mean Rank Cases 
7.00 
6.00 
6 GROUP 
6 GROUP 
12 Total 
1. 00 CFS 
2.00 control 
Corrected for ties 
Z 2-Tailed P u 
15.0 
w 
42.0 
Exact 
2-Tailed P 
.6991 -1.0000 .3173 
- - - - - Mann-Whitney u - Wilcoxon Rank sum W Test 
RPE20 
by GROUP 
RPE at 20% TOT 
Mean Rank Cases 
8.58 6 GROUP 1.00 CFS 
4.42 6 GROUP 
" 
2.00 control 
12 Total 
Exact Corrected for ties 
u w 2-Tailed p z 2-Tailed P 
5.5 51.5 ,0411 -2.0266 .0427 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum w Test 
RPE40 
by GROUP 
Mean Rank 
7.67 
5.33 
u 
11.0 
RPE at 40% TOT 
cases 
6 GROUP 
6 GROUP 
12 Total 
w 
46.0 
1.00 CFS 
2.00 control 
Exact Corrected for ties 
2-Tailed p Z 2-Tailed P 
.3095 -1.1515 .2495 
-- ---Mann-Whitney U- ni]coxon Rank sum W Test 
RPE60 
by GROUP 
Mean Rank 
7.17 
5.83 
u 
14.0 
RPe at 60% TOT 
cases 
6 GROUP 
6 GROUP 
12 Total 
w 
43.0 
1. 00 CFS 
" 
2.00 control 
Exact Corrected for ties 
2-Tailed p Z 2-Tailed P 
. 5887 -.6556 .5121 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
RPE80 
by GROUP 
Mean Rank 
6.67 
6.33 
u 
17 .o 
RPE at 80% TOT 
Cases 
6 GROUP 
6 GROUP 
12 Total 
w 
40.0 
1.00 CFS 
2.00 control 
Exact Corrected for ties 
2-Tailed p Z 2-Tailed P 
. 9372 -.1925 ,8474 
- - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
RPESTART RPE at start 
by GROUP 
Mean Rank 
8.75 
4.25 
Cases 
6 GROUP 1, 00 CFS 
6 GROUP= 2.00 control 
12 Total 
u 
4. 5 
w 
52.5 
Exact 
2-Tailed I' 
.0260 
Corrected for ties 
Z 2-Tailed P 
-2.2249 .0261 
- - - - Mann-Whitney u - Wilcoxon Rank Sum w Test 
SPlOO 
by GROUP 
Mean Rank 
3.50 
9.50 
u 
.0 
SP duration at 100% TOT 
cases 
6 GROUP = 1.00 CFS 
6 GROUP 2.00 control 
12 Total 
w 
21.0 
Exact 
2-Tailed P 
.0022 
corrected for ties 
Z 2-Tailed P 
-2.8823 .0039 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
SP20 SP duration at 20% TOT 
by GROUP 
Mean Rank 
4.92 
8.08 
u 
8. 5 
Cases 
6 GROUP 
6 GROUP 
12 Total 
w 
29.5 
" 
1.00 CFS 
2.00 control 
Exact 
2-Tailed p 
.1320 
corrected for ties 
Z 2-Tailed P 
-1.5239 .1275 
- - - - - Mann-Whitney u - Wilcoxon Rank Sum W Test 
SP40 SP duration at 40% TOT 
by GROUP 
Mean Rank Cases 
3.50 
9.50 
u 
.0 
6 GROUP ~ 1.00 CFS 
6 GROUP 2.00 control 
12 Total 
w 
21.0 
Exact 
2-Tailed P 
.0022 
- - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
SP60 SP duration at 60% TOT 
by GROUP 
Mean Rank 
3.83 
9.17 
u 
2.0 
cases 
6 
6 
12 
GROUP 
GROUP 
Total 
w 
2-3. 0 
1.00 CFS 
" 
2. O·J control 
Exact 
2-Tailed p 
. oo:n 
corrected for ties 
Z 2-Tai1ed P 
-2.8823 .0039 
corrected for ties 
Z 2-Tailed P 
-2.5621 .0104 
Mann-Whitney U - Wilcoxon Rank Sum W Test 
SPSO SP duration at 80% TOT 
by GROUP 
Mean Rank 
4.50 
8.50 
cases 
6 GROUP = 1.00 CFS 
6 GROUP = 2.00 control 
12 Total 
Corrected for ties 
Z 2-Tailed P u 
6.0 
w 
27.0 
Exact 
2-Tailed P 
. 0649 -1.9215 .0547 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
SPSTART 
by GROUP 
Mean Rank 
REP100 
RPE20 
RPE40 
RPE60 
RPE80 
RPESTART 
6.33 
6.67 
u 
17.0 
SP duration at start 
Cases 
6 GROUP = 1.00 CFS 
6 GROUP = 2.00 control 
N 
12 
12 
12 
12 
12 
12 
12 Total 
w 
38.0 
Mean 
19.83333 
13.08333 
15.91667 
18.08333 
19.41667 
10.16667 
Exact 
2-Tailed P 
.9372 
std Dev 
.57735 
1. 83196 
2.15146 
1. 56428 
1.16450 
1. 64225 
Minimum 
18.00 
10.00 
12.00 
15.00 
16.00 
8.00 
- - - - - Friedman Two-Way An ova 
Mean Rank variable 
5.58 REP100 RPE at 100% TOT 
2.00 RPE20 RPE at 20% TOT 
3.00 RPE40 RPE at 40% TOT 
4.17 RPE60 RPe at 60% TOT 
5.25 RPE80 RPE at 80% TOT 
1.00 RPESTART RPE at start 
Cases Chi-Square o.F. 
12 56.9048 5 
corrected for ties 
z 2-Tailed P 
-.1601 .8728 
Maximum 
20.00 
16.00 
18.00 
20.00 
20.00 
14.00 
Significance 
.0000 
- - - - - Mann-Whitney U - Wilcoxon Rank sum W Test 
SPlOO 
by GROUP 
Mean Rank 
3.50 
9.50 
SP duration at 100% TOT 
Cases 
6 GROUP = 1.00 CFS 
6 GROUP 2.00 control 
12 Total 
Exact Corrected for ties 
w 2-Tailed p Z 2-Tailed P u 
.0 21.0 .0022 -2.8823 .0039 
- - - - - Mann-Whitney U - Wilcoxon Rank Sum W Test 
SPSTART SP duration at start 
by GROUP 
Mean Rank Cases 
6.33 
6.67 
6 GROUP= 1.00 CFS 
6 GROUP 2.00 control 
12 Total 
Exact 
2-Tailed P 
.9372 
Corrected for ties 
u 
17.0 
w 
38.0 
Z 2-Tailed P 
-.1601 .8728 
- Description of Subpopulations 
Sununaries of 
By levels of 
SPSTART 
GROUP 
SP duration at start 
Variable Value Label 
For Entire Population 
GROUP 1.00 CFS 
GROUP 2.00 control 
Total Cases 16 
Missing Cases = 4 or 25.0 Pet 
N Mean 
MEPlOO 6 10.10500 
RATI0100 6 .28333 
REP100 6 19.66667 
SP100 6 186.33333 
MEPSTART 6 8.26000 
RATIO 0 6 .48333 
RPEO. 0 6 9.16667 
SPSTART 6 118.66666 
- Wilcoxon Matched-Pairs 
MEP100 MEP at 100% TOT 
with MEPSTART MEP at O'!i 
Mean Rank Cases 
3. 60 5 - Ranks 
3.00 1 + Ranks 
0 Ties 
6 Total 
z = -1.5724 
sum 
1355.00 
643.00 
712.00 
Mean 
112.9167 
107.1667 
118.6667 
Std Dev Minimum Maximum 
3. 86707 4.45 15.64 
.09832 .20 .40 
.81650 18.00 20.00 
51.26662 126.00 262.00 
5. 91863 1.59 17.48 
.22286 .30 .80 
1.16905 8.00 11.00 
38.46384 87.00 189.00 
Signed-Ranks Test 
(MEPSTART LT MEP100) 
(MEPSTART GT MEP100) 
(MEPSTART EQ r.mplOO) 
2-Tailed P = .1159 
Std Dev 
29.3272 
18.2583 
38.4638 
cases 
12 
6 
6 
- - - - - Wilcoxon Matched-Pairs Signed-Ranks Test 
RATI0100 
with RATIO 0 
Mean Rank 
2.00 
4.25 
z = 
twitch ratio 
twitch ratio 
cases 
at 100% 
at start 
-1.3628 
2 
4 
0 
- Ranks 
+ Ranks 
Ties 
6 TOtal 
(RATIO_O LT RATI0100) 
(RATIO 0 GT RATIOlOO) 
(RATIO:o EQ RATI0100) 
2-Tailed P = .1730 
- Wilcoxon Matched-Pairs Signed-Ranks Test 
REP100 RPE at 100% TOT 
with RPEO.O RPE at start 
Mean Rank cases 
3.50 
.00 
z = -2.2014 
6 
0 
0 
- Ranks 
+ Ranks 
Ties 
6 Total 
(RPEO.O LT REP100) 
(RPEO.O GT REP100) 
(RPEO.O EQ REPlOO) 
2-Tailed P = . 0277 
- Wilcoxon Matched-Pairs Signed-Ranks Test 
SP100 
with SPSTART 
Mean Rank 
3.50 
.00 
z = 
29 oct 96 SPSS 
SP duration at 100% TOT 
SP duration at start 
cases 
6 - Ranks (SPSTART 
0 + Ranks (SPSTART 
0 Ties (SPSTART 
6 TOtal 
-2.2014 2-Tailed 
for MS WINDOWS Release 6.0 
LT SPlOO) 
GT SPlOO) 
EQ SPlOO) 
p .0277 
N Mean Std oev Minimum Maximum 
RATIOlOO 6 .31667 . 09832 .20 .50 
REP100 6 20.00000 . 00000 20.00 20.00 
SP100 6 99.50000 18.75900 79.00 125.00 
FINISH 6 6.36500 2.90962 2. 70 10.12 
RATIO ST 6 .48333 . 1834 8 .30 .so 
RPESTART 6 11.16667 1.47196 10.00 14.00 
SPSTART 6 107.16666 18.25833 88.00 140.00 
MEPSTART 6 5.53167 2.44106 2.87 9.87 
Wilcoxon Matched-Pairs Signed-Ranks Test 
RATI0100 twitch ratio at 100% 
with RATIO ST twitch ratio at start 
Mean Rank cases 
2.50 1 - Ranks (RATIO_ST LT RATIOlOO) 
3.70 5 + Ranks (RATIO_ST GT RATIOlOO) 
0 Ties (RATIO_ST EQ RATIOlOO) 
6 Total 
z = -1.6773 2-Tailed P = .0935 
- - - - - Wilcoxon Matched-Pairs Signed-Ranks Test 
REP100 RPE at 100% TOT 
with RPESTART RPE at start 
Mean Rank cases 
' ~ ,'' 
3.50 
.00 
z = -2.2014 
6 
0 
0 
- Ranks 
+ Ranks 
Ties 
6 Total 
(RPESTART LT REP100) 
(RPESTART GT REPlOO) 
(RPESTART EQ REPlOO) 
2-Tailed P ~ .0277 
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- - - - - Wilcoxon Matched-Pairs Signed-Ranks Test 
SPlOO 
with SPSTART 
Mean Rank 
3.00 
3.75 
z = 
SP duration at 100% TOT 
SP duration at start 
Cases 
-.9435 
2 - Ranks (SPSTART LT SPlOO) 
4 + Ranks (SPSTART GT SP!OO) 
0 Ties (SPSTART EQ SPlOO) 
6 Total 
2-Tailed P = .3454 
- Wilcoxon Matched-Pairs Signed-Ranks Test 
FINISH 100% TOT 
with MEPSTART start 
Mean Rank Cases 
4.00 3 - Ranks (MEPSTART LT FINISH) 
3.00 3 + Ranks (MEPSTART GT FINISH) 
0 Ties (MEPSTART EQ FINISH) 
6 Total 
z -.3145 2-Tailed P .7532 
* * * * * * A n a 1 y s i s 0 f V a r i a n c e -- design 
Adjusted and Estimated Means 
Variable MVC PRE 
CELL obs. Mean Adj. Mean Est. Mean Raw Resid. 
1 123.467 142.915 123.467 .ooo 
2 170.100 150,652 170.100 .000 
* * * * * * A n a 1 y s i s 0 f V a r i a n c e -- design 
Combined Adjusted Means for GROUP 
Variable •• MVC_PRE 
GROUP 
CFS UNWGT. 142.91484 
control UNWGT. 150.65183 
1****** 
Std. Resid. 
. 000 
.000 
1****** 
- - - - -
- - - - - -
- - - -
- -
-
- -
-
- - - - - -
N Mean Std Dev Minimum Maximum 
MVC PRE 11 144.66364 53.34859 80.00 226 .so 
-HVC FAT 11 74.09091 34.72891 28.30 148.30 
MVC-REC 11 120.86364 60.53973 53.10 224.00 
Friedman Two-Way Anova 
Mean Rank Variable 
2.82 MVC PRE 
1.00 MVC FAT MVC at end of fatigue protocol 
2.18 MVC-REC MVC post recovery 
Cases Chi-Square D.F. Significance 
11 18.7273 2 .0001 
N Mean Std Dev Minimum Maximum 
MVC PRE 11 144.66364 53.34859 80.00 226.80 
MVC-FAT 11 74.09091 34.72891 29.30 148.30 
MVC REC 11 120.96364 60.5397 3 53.10 224.00 
GROUP 11 1.45455 .52223 1.00 2.00 
(Median) 
25th 50th 75th 
N Percentile Percentile Percentile 
MVC PRE 11 100.7000 118.0000 200.0000 
MVC FAT 11 48.2000 70.1000 95.9000 
MVC_REC 11 81. 6000 94.6000 166.6000 
GROUP 11 1.0000 1.0000 2.0000 
Friedman Two-Way An ova 
Mean Rank Variable 
3.82 
2.00 
3.19 
1. 00 
Cases 
11 
MVC PRE 
MVC FAT 
MVC REC 
GROUP 
MVC at end of fatigue protocol 
MVC post recovery 
Chi-Square 
31.0364 
D. F. 
3 
Significance 
.0000 
APPENDIX G 
History and Status of Participants in the CFS Group 
-~· 
DOB 
gender 
A fleeted 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
code 
DOB 
gender 
Affected 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
CFS 1 0 post-viral 6m - 2yr 
10/12/67 181 post-viral 2 - 5 yr 
F 0 non-viral 
5 years (2 badly) 0 Psych 
2 years 181 Acceptable 
Dr Alistar Nuttall 
Beufort St, Inglewood, 6052 
Prothiadene (antiinflammatory) 
Suspect recurring bouts of glandular fever 
triggered onset. 
CFS 2 0 post-viral 6m- 2yr 
3/12/48 181 post-viral 2 - 5 yr 
M 0 non-viral 
3 yrs 0 Psych 
3 yrs 181 Acceptable 
Dr Chris Denz 
Forest Chase 
Arourex (1200mg) 
Lethargy, run down, concentration loss, out of 
sorts. Positive for Ross river, Glandular fever, 
Cytomega virus. 
code 
DOB 
gender 
Affected 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
code 
DOB 
gender 
Affected 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
CFS 3 D post-viral 6m - 2yr 
24/10/49 181 post-viral 2 - 5 yr 
F D non-viral 
4 yrs D Psych 
4 yrs 181 Acceptable 
Dr Papaelias (gp) 
Prozac 
Exhaustion, sore throat, headaches, weak & 
shaky all day. Related to stress at work & 
following relation break up. Now single. 
CFS 4 181 post-viral 6m - 2yr 
23/10/69 D post-viral 2 - 5 yr 
M D non-viral 
May96 D Psych 
6/96 181 Acceptable 
Dr Chris Denz 
Forest Chase 
Tryptanol, vitamins. 
Ross River virus onset May. nagging 
tiredness, chest pains (sternum), increasing 
tiredness, became bed ridden. 
code 
DOB 
gender 
Affected 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
code 
DOB 
gender 
Affected 
Diagnosed 
Physician 
Address (Dr) 
Medication 
Symptom 
onset 
CFS 5 181 post-viral 6m - 2yr 
14/10/77 D post-viral 2 - 5 yr 
F D non-viral 
6 months D Psych 
4 months 181 Acceptable 
Dr Chris Denz 
Forest Chase Medical Centre 
None 
Recurring fatigue following glandular fever, 
headaches, fatigue, dizziness. 
CFS 6 181 post-viral 6m - 2yr 
18/6/78 D post-viral 2 - 5 yr 
F D non-viral 
1 year D Psych 
9 months 181 Acceptable 
Dr 
Vitamin supplements 
Glandular fever (3rd time), never seemed to 
recover. 
APPENDIX H 
Activity Index 
Activity Index 
Based on your regular daily activity, calculate your activity index 
by multiplying your score for each of the three categories (score 
= frequency x intensity x time) 
Daily Activity Score 
Frequency 
Daily or almost daily 5 
3 to 5 times per week 4 
1 to 2 times per week 3 
A few times per month 2 
Less than once a month 1 
Intensity 
Sustained heavy breathing and 
perspiration (running etc) 5 
Intermittent heavy breathing and 
perspiration (tennis jogging) 4 
Moderately heavy 
(recreation sports or cycling etc) 3 
Moderate ( softball, golf etc) 2 
Light r fishing, walking etc) 1 
Time 
Over 30 min 4 
20 to 30 min 3 
10 to 20 min 2 
under 10 min 1 
Total Score X X 
Name 
Height Weight Age 
Central Fatigue - PH 1996 
APPENDIX I 
Data Collection Sheets 
CFS BICEPS FATIGUE TEST 
Patient. ................................................................... . dab ........... : .......................... . 
dot. ............................... . filename ................................ · 
comments 
n-i.............. i-J.............. sapphire gain........................... max rms ....................................... .. 
sites used ........................ .. threshold ............................ .. intensity .......................... .. 
lever arm ........... . resting force ............. . MVC ..................... (20% .............. ) 
min PE rms comments 
.......................................................................................... ' ......................... " .................................... . 
................................................................................................... ························································ 
.......................................................................................................................................... ' ........... " .. . 
........................................................................................................................................................... 
. . ..... " ..... """ .................... " .................... " ............. " .......................................................................... .. 
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........................................................................................................................................................... 
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........................................................................................................................................................... 
........................................................................................................................................................... 
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........................................................................................................................................................... 
........................................................................................................................................................... 
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........................................................................................................................................................... 
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........................................................................................................................................................... 
........................................................................................................................................................... 
........................................................................................................................................................... 
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